Ident. | Authors (with country if any) | Title |
---|
000001 |
Alexandre Eusebio [France] ; Tatiana Witjas [France] ; Julien Cohen [France] ; Frédérique Fluchère [France] ; Elisabeth Jouve [France] ; Jean Régis [France] ; Jean-Philippe Azulay [France] | Subthalamic nucleus stimulation and compulsive use of dopaminergic medication in Parkinson's disease |
000005 |
Franziska Maier [Allemagne] ; Catharine J. Lewis [Allemagne] ; Nina Horstkoetter [Allemagne] ; Carsten Eggers [Allemagne] ; Elke Kalbe [Allemagne] ; Mohammad Maarouf [Allemagne] ; Jens Kuhn [Allemagne] ; Mateusz Zurowski [Canada] ; Elena Moro [France] ; Christiane Woopen [Allemagne] ; Lars Timmermann [Allemagne] | Patients’ expectations of deep brain stimulation, and subjective perceived outcome related to clinical measures in Parkinson's disease: a mixed-method approach |
000006 |
Kathryn N. Parkinson [Royaume-Uni] ; Heather O. Dickinson [Royaume-Uni] ; Catherine Arnaud [France] ; Alan Lyons [Irlande (pays)] ; Allan Colver [Royaume-Uni] ; Eva Beckung ; Jackie Parkes ; Jérôme Fauconnier ; Alan Lyons ; Susan Michelsen ; Marco Marcelli ; Catherine Arnaud ; Ute Thyen ; Marion Rapp | Pain in young people aged 13 to 17 years with cerebral palsy: cross-sectional, multicentre European study |
000016 |
D C Consonni [Italie] ; Straif [France] ; Symons [États-Unis] ; Tomenson [Royaume-Uni] ; Amelsvoort Van [Pays-Bas] ; Sleeuwenhoek [Royaume-Uni] ; Cherrie [Royaume-Uni] ; Bonetti [Italie] ; Colombo [Italie] ; Farrar [Royaume-Uni] ; Carugno [Italie] ; Bertazzi [Italie] | 284 Cancer risk among tetrafluoroethylene (TFE) synthesis and polymerisation workers |
000040 |
Audrey Maillet [France] ; Pierre Pollak [France, Suisse] ; Bettina Debû [France] | Imaging gait disorders in parkinsonism: a review |
000048 |
Manu Sharma ; John P A. Ioannidis [États-Unis] ; Jan O. Aasly [Norvège] ; Grazia Annesi [Italie] ; Alexis Brice [France] ; Lars Bertram [Allemagne] ; Maria Bozi [Grèce] ; Maria Barcikowska [Pologne] ; David Crosiers [Belgique] ; Carl E. Clarke [Royaume-Uni] ; Maurizio F. Facheris ; Matthew Farrer [Canada] ; Gaetan Garraux ; Suzana Gispert [Allemagne] ; Georg Auburger ; Carles Vilari O-Güell [Canada] ; Georgios M. Hadjigeorgiou [Grèce] ; Andrew A. Hicks ; Nobutaka Hattori [Japon] ; Beom S. Jeon [Corée du Sud] ; Zygmunt Jamrozik [Pologne] ; Anna Krygowska-Wajs [Pologne] ; Suzanne Lesage [France] ; Christina M. Lill [Grèce, Allemagne] ; Juei-Jueng Lin [Taïwan] ; Timothy Lynch [Irlande (pays)] ; Peter Lichtner [Allemagne] ; Anthony E. Lang [Canada] ; Cecile Libioulle [Canada] ; Miho Murata [Japon] ; Vincent Mok [Hong Kong] ; Barbara Jasinska-Myga [Pologne] ; George D. Mellick [Australie] ; Karen E. Morrison [Royaume-Uni] ; Thomas Meitnger [Allemagne] ; Alexander Zimprich [Autriche] ; Grzegorz Opala [Allemagne] ; Peter P. Pramstaller ; Irene Pichler ; Sung Sup Park [Allemagne] ; Aldo Quattrone [Italie] ; Ekaterina Rogaeva [Canada] ; Owen A. Ross [États-Unis] ; Leonidas Stefanis [Grèce] ; Joanne D. Stockton [Royaume-Uni] ; Wataru Satake [Japon] ; Peter A. Silburn [Australie] ; Tim M. Strom [Allemagne, Canada] ; Jessie Theuns [Belgique] ; Eng- King Tan [Singapour] ; Tatsushi Toda [Japon] ; Hiroyuki Tomiyama [Japon] ; Ryan J. Uitti [États-Unis] ; Christine Van Broeckhoven [Belgique] ; Karin Wirdefeldt ; Zbigniew Wszolek [États-Unis] ; Georgia Xiromerisiou [Grèce] ; Harumi S. Yomono [Japon] ; Kuo-Chu Yueh [Taïwan] ; Yi Zhao ; Thomas Gasser ; Demetrius Maraganore [États-Unis] ; Rejko Krüger | A multi-centre clinico-genetic analysis of the VPS35 gene in Parkinson disease indicates reduced penetrance for disease-associated variants |
000068 |
Jane A. Driver [États-Unis] ; Giancarlo Logroscino [Italie] ; Linda Lu [États-Unis] ; J Michael Gaziano [États-Unis] ; Tobias Kurth [France] | Use of non-steroidal anti-inflammatory drugs and risk of Parkinson’s disease: nested case-control study |
000082 |
Maud Ranchet [France] ; Laurence Paire-Ficout [France] ; Claude Marin-Lamellet [France] ; Bernard Laurent [France] ; Emmanuel Broussolle [France] | Impaired updating ability in drivers with Parkinson's disease |
000084 |
Gilles Fénelon [France] ; Thierry Soulas [France] ; Laurent Cleret De Langavant [France] ; Iris Trinkler [France] ; Anne-Catherine Bachoud-Lévi [France] | Feeling of presence in Parkinson's disease |
000090 |
Yan Rolland [France] ; Marc Vérin [France] ; Christine A. Payan [France] ; Simon Duchesne [Canada] ; Eduard Kraft [Allemagne] ; Till K. Hauser [Allemagne] ; Josef Jarosz [Royaume-Uni] ; Neil Deasy [Royaume-Uni] ; Luc Defevbre [France] ; Christine Delmaire [France] ; Didier Dormont [France] ; Albert C. Ludolph [Allemagne] ; Gilbert Bensimon [France] ; P Nigel Leigh [Royaume-Uni, France] | A new MRI rating scale for progressive supranuclear palsy and multiple system atrophy: validity and reliability |
000095 |
Angelo Antonini [Italie] ; Pablo Martinez-Martin [Espagne] ; Ray K. Chaudhuri [Royaume-Uni] ; Marcelo Merello [Argentine] ; Robert Hauser [États-Unis] ; Regina Katzenschlager [Autriche] ; Per Odin [Allemagne] ; Mark Stacy [États-Unis] ; Fabrizio Stocchi [Italie] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Cristina Sampaio [Portugal] ; Anette Schrag [Royaume-Uni] ; Glenn T. Stebbins [États-Unis] ; Christopher G. Goetz [États-Unis] | Wearing‐off scales in Parkinson's disease: Critique and recommendations |
000118 |
Frédéric Moisan [France] ; Johan Spinosi [France] ; Jean-Luc Dupupet [France] ; Laurène Delabre [France] ; Jean-Louis Mazurie [France] ; Marcel Goldberg [France] ; Ellen Imbernon [France] ; Christophe Tzourio [France] ; Alexis Elbaz [France] | The relation between type of farming and prevalence of Parkinson's disease among agricultural workers in five french districts |
000135 |
Anne Pavy-Le Traon [France] ; Gerard Amarenco [France] ; Susanne Duerr [Autriche] ; Horacio Kaufmann [États-Unis] ; Heinz Lahrmann [Autriche] ; Stephanie R. Shaftman [États-Unis] ; François Tison [France] ; Gregor K. Wenning [Autriche] ; Christopher G. Goetz [États-Unis] ; Werner Poewe [Autriche] ; Cristina Sampaio [Portugal] ; Anette Schrag [Royaume-Uni] ; Glenn T. Stebbins [États-Unis] ; Olivier Rascol [France] | The Movement Disorders task force review of dysautonomia rating scales in Parkinson's disease with regard to symptoms of orthostatic hypotension |
000136 |
Klaus Seppi [Autriche, Portugal] ; Daniel Weintraub [États-Unis] ; Miguel Coelho [Portugal] ; Santiago Perez-Lloret [France] ; Susan H. Fox [Canada] ; Regina Katzenschlager [Autriche] ; Eva-Maria Hametner [Autriche] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Christopher G. Goetz [États-Unis] ; Cristina Sampaio [Portugal] | The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the non‐motor symptoms of Parkinson's disease |
000137 |
Susan H. Fox [Canada] ; Regina Katzenschlager [Autriche] ; Shen-Yang Lim [Malaisie] ; Bernard Ravina [États-Unis] ; Klaus Seppi [Autriche] ; Miguel Coelho [Portugal] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Christopher G. Goetz [États-Unis] ; Cristina Sampaio [Portugal] | The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease |
000138 |
Jean-Christophe Corvol [France] ; Cécilia Bonnet [France] ; Fanny Charbonnier-Beaupel [France] ; Anne-Marie Bonnet [France] ; Marie-Hélène Fiévet ; Agnès Bellanger ; Emmanuel Roze [France] ; Gayané Meliksetyan [France] ; Mouna Ben Djebara [France] ; Andreas Hartmann [France] ; Lucette Lacomblez [France] ; Cédric Vrignaud [France] ; Noël Zahr [France] ; Yves Agid [France] ; Jean Costentin [France] ; Jean-Sébastien Hulot [France] ; Marie Vidailhet [France] | The COMT Val158Met polymorphism affects the response to entacapone in Parkinson's disease: A randomized crossover clinical trial |
000146 |
Hélène Mollion [France] ; Peter Ford Dominey [France] ; Emmanuel Broussolle [France] ; Jocelyne Ventre-Dominey [France] | Subthalamic nucleus stimulation selectively improves motor and visual memory performance in Parkinson's disease |
000149 |
Brigitte Piallat [France] ; Mircea Polosan [France] ; Valérie Fraix [France] ; Laurent Goetz [France] ; Olivier David [France] ; Albert Fenoy [France] ; Napoleon Torres [France] ; Jean-Louis Quesada [France] ; Eric Seigneuret [France] ; Pierre Pollak [France] ; Paul Krack [France] ; Thierry Bougerol [France] ; Alim-Louis Benabid [France] ; Stéphan Chabardès [France] | Subthalamic neuronal firing in obsessive‐compulsive disorder and Parkinson disease |
000162 |
Eugénie Mutez [France] ; Frédéric Leprêtre [France] ; Emilie Le Rhun [France] ; Lydie Larvor [France] ; Aurélie Duflot [France] ; Vincent Mouroux [France] ; Jean-Pierre Kerckaert [France] ; Martin Figeac [France] ; Kathy Dujardin [France] ; Alain Destée [France] ; Marie-Christine Chartier-Harlin [France] | SNCA locus duplication carriers: from genetics to Parkinson disease phenotypes |
000184 |
Wassilios G. Meissner [France] ; Mark Frasier [États-Unis] ; Thomas Gasser [Allemagne] ; Christopher G. Goetz [États-Unis] ; Andres Lozano [Canada] ; Paola Piccini [Royaume-Uni] ; José A. Obeso [Espagne] ; Olivier Rascol [France] ; Anthony Schapira [Royaume-Uni] ; Valerie Voon [Royaume-Uni] ; David M. Weiner [États-Unis] ; François Tison [France] ; Erwan Bezard [France] | Priorities in Parkinson's disease research |
000208 |
Cristina Sampaio [Portugal] ; Juliana Bronzova [Pays-Bas] ; Robert A. Hauser [États-Unis] ; Anthony E. Lang [Canada] ; Olivier Rascol [France] ; Serge V. Van De Witte [Pays-Bas] ; And Ad Theeuwes [Pays-Bas] | Pardoprunox in early Parkinson's disease: Results from 2 large, randomized double‐blind trials |
000210 |
Veit Mylius [Allemagne, France] ; Juliane Brebbermann [Allemagne] ; Helena Dohmann [Allemagne] ; Isabel Engau [Allemagne] ; Wolfgang H. Oertel [Allemagne] ; Jens C. Möller [Allemagne, Suisse, France] | Pain sensitivity and clinical progression in Parkinson's disease |
000226 |
Benjamin Dehay [France] ; Erwan Bezard [France] | New animal models of Parkinson's disease |
000254 |
Olivier Rascol [France] ; Andres Lozano [Canada] ; Matthew Stern [États-Unis] ; Werner Poewe [Autriche] | Milestones in Parkinson's disease therapeutics |
000267 |
Peggy Reiner [France] ; Damien Galanaud [France] ; Gaëlle Leroux [France] ; Marie Vidailhet [France] ; Julien Haroche [France] ; Du Le Thi Huong [France] ; Camille Francès [France] ; Thomas Papo [France] ; Christian De Gennes [France] ; Lucile Musset [France] ; Bertrand Wechsler [France] ; Zahir Amoura [France] ; Jean-Charles Piette [France] ; Nathalie Costedoat-Chalumeau [France] | Long‐term outcome of 32 patients with chorea and systemic lupus erythematosus or antiphospholipid antibodies |
000287 |
Alexis Elbaz [France] ; Owen A. Ross [États-Unis] ; John P. A. Ioannidis [Grèce, États-Unis] ; Alexandra I. Soto-Ortolaza [États-Unis] ; Frédéric Moisan [France] ; Jan Aasly [Norvège] ; Grazia Annesi [Italie] ; Maria Bozi [Grèce] ; Laura Brighina [Italie] ; Marie-Christine Chartier-Harlin [France] ; Alain Destée [France] ; Carlo Ferrarese [Italie] ; Alessandro Ferraris [Italie] ; J. Mark Gibson [Irlande (pays)] ; Suzana Gispert [Allemagne] ; Georgios M. Hadjigeorgiou [Grèce] ; Barbara Jasinska-Myga [Pologne] ; Christine Klein [Allemagne] ; Rejko Krüger [Allemagne] ; Jean-Charles Lambert [France] ; Katja Lohmann [Allemagne] ; Simone Van De Loo [Allemagne] ; Marie-Anne Loriot [France] ; Timothy Lynch [Irlande (pays)] ; George D. Mellick [Australie] ; Eugénie Mutez [France] ; Christer Nilsson [Suède] ; Grzegorz Opala [Pologne] ; Andreas Puschmann [Suède] ; Aldo Quattrone [Italie] ; Manu Sharma [Allemagne] ; Peter A. Silburn [Australie] ; Leonidas Stefanis [Grèce] ; Ryan J. Uitti [États-Unis] ; Enza Maria Valente [Italie] ; Carles Vilari O-Güell [États-Unis, Canada] ; Karin Wirdefeldt [Suède] ; Zbigniew K. Wszolek [États-Unis] ; Georgia Xiromerisiou [Grèce] ; Demetrius M. Maraganore [États-Unis] ; Matthew J. Farrer [États-Unis, Canada] | Independent and joint effects of the MAPT and SNCA genes in Parkinson disease |
000298 |
Ingrid De Chazeron [France] ; Pierre-Michel Llorca [France] ; Isabelle Chéreau-Boudet [France] ; Olivier Blanc [France] ; Jean Perriot [France] ; Lemlih Ouchchane [France] ; Miguel Ulla [France] ; Bérengère Debilly [France] ; Philippe Derost [France] ; Franck Durif [France] | Hypersexuality and pathological gambling in Parkinson's disease: A cross‐sectional case–control study |
000302 |
Pablo Martinez-Martin [Espagne] ; Martine Jeukens-Visser [Pays-Bas] ; Kelly E. Lyons [États-Unis] ; C. Rodriguez-Blazquez [Espagne] ; Caroline Selai [Royaume-Uni] ; Andrew Siderowf [États-Unis] ; Mickie Welsh [États-Unis] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Cristina Sampaio [Portugal] ; Glenn T. Stebbins [États-Unis] ; Christopher G. Goetz [États-Unis] ; Anette Schrag [Royaume-Uni] | Health‐related quality‐of‐life scales in Parkinson's disease: Critique and recommendations |
000332 |
Emmanuelle Bondon-Guitton [France] ; Santiago Perez-Lloret [France] ; Haleh Bagheri [France] ; Christine Brefel [France] ; Olivier Rascol [France] ; Jean-Louis Montastruc [France] | Drug‐induced parkinsonism: A review of 17 years' experience in a regional pharmacovigilance center in France |
000333 |
Olivier Rascol [France] | Drugs and drug delivery in PD: optimizing control of symptoms with pramipexole prolonged‐release |
000341 |
E. Mulin [France] ; E. Leone [France] ; K. Dujardin [France] ; M. Delliaux [France] ; A. Leentjens [Pays-Bas] ; F. Nobili [Italie] ; B. Dessi [Italie] ; O. Tible [France] ; L. Agüera-Ortiz [Espagne] ; R. S. Osorio [Espagne] ; J. Yessavage [États-Unis] ; D. Dachevsky [Argentine] ; F. Rj. Verhey [Pays-Bas] ; Alfonso J. Cruz Jentoft [Espagne] ; O. Blanc [France] ; P. M Llorca [France] ; P. H. Robert [France] | Diagnostic criteria for apathy in clinical practice |
000409 |
Erwan Bezard [France] ; Serge Przedborski [États-Unis] | A tale on animal models of Parkinson's disease |
000445 |
Suzanne Lesage ; Etienne Patin ; Christel Condroyer ; Anne-Louise Leutenegger ; Ebba Lohmann ; Nir Giladi ; Anat Bar-Shira ; Soraya Belarbi ; Nassima Hecham ; Pierre Pollak [Suisse] ; Anne-Marie Ouvrard-Hernandez ; Soraya Bardien ; Jonathan Carr ; Traki Benhassine ; Hiroyuki Tomiyama ; Caroline Pirkevi ; Tarik Hamadouche ; Ccile Cazeneuve [France] ; A. Nazli Basak ; Nobutaka Hattori ; Alexandra Drr [France] ; Meriem Tazir ; Avi Orr-Urtreger ; Lluis Quintana-Murci ; Alexis Brice [France] ; Yves Agid [France] ; A.-M. Bonnet ; M. Borg ; A. Brice ; E. Broussolle ; Ph. Damier ; A. Deste ; A. Drr ; F. Durif ; E. Lohmann ; M. Martinez ; C. Penet ; Pierre Pollak [Suisse] ; Olivier Rascol [France] ; F. Tison ; C. Tranchant ; A. Troiano ; M. Vrin ; F. Viallet ; M. Vidailhet | Parkinson's disease-related LRRK2 G2019S mutation results from independent mutational events in humans |
000450 |
Stphane Thobois [France] ; Claire Ardouin [France] ; Eugnie Lhomme [France] ; Hlne Klinger [France] ; Christelle Lagrange [France] ; Jing Xie [France] ; Valrie Fraix [France] ; Maria Clara Coelho Braga [France] ; Rachid Hassani [France, Maroc] ; Andrea Kistner [France] ; Alexandra Juphard [France] ; Eric Seigneuret [France] ; Stephan Chabardes [France] ; Patrick Mertens [France] ; Gustavo Polo [France] ; Anthonin Reilhac [France] ; Nicolas Costes [France] ; Didier Lebars [France] ; Marc Savasta [France] ; Lon Tremblay [France] ; Jean-Louis Quesada [France] ; Jean-Luc Bosson [France] ; Alim-Louis Benabid [France] ; Emmanuel Broussolle [France] ; Pierre Pollak [France] ; Paul Krack [France] | Non-motor dopamine withdrawal syndrome after surgery for Parkinsons disease: predictors and underlying mesolimbic denervation |
000456 |
Patrice Pran [Italie, France] ; Andrea Cherubini [Italie] ; Francesca Assogna [Italie] ; Fabrizio Piras [Italie] ; Carlo Quattrocchi [Italie] ; Antonella Peppe [Italie] ; Pierre Celsis [France] ; Olivier Rascol [France] ; Jean-Franois Dmonet [France] ; Alessandro Stefani [Italie] ; Mariangela Pierantozzi [Italie] ; Francesco Ernesto Pontieri [Italie] ; Carlo Caltagirone [Italie] ; Gianfranco Spalletta [Italie] ; Umberto Sabatini [Italie] | Magnetic resonance imaging markers of Parkinsons disease nigrostriatal signature |
000477 |
Richard G. Brown [Royaume-Uni] ; Lucette Lacomblez [France] ; Bernard G. Landwehrmeyer [Allemagne] ; Thomas Bak [Royaume-Uni] ; Ingo Uttner [Allemagne] ; Bruno Dubois [France] ; Yves Agid [France] ; Albert Ludolph [Allemagne] ; Gilbert Bensimon [France] ; Christine Payan [France] ; Nigel P. Leigh [Royaume-Uni] | Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy |
000530 |
Carlo Colosimo [Italie] ; Pablo Martínez-Martín [Espagne] ; Giovanni Fabbrini [Italie] ; Robert A. Hauser [États-Unis] ; Marcelo Merello [Argentine] ; Janis Miyasaki [Canada] ; Werner Poewe [Autriche] ; Cristina Sampaio [Portugal] ; Olivier Rascol [France] ; Glenn T. Stebbins [États-Unis] ; Anette Schrag [Royaume-Uni] ; Christopher G. Goetz [États-Unis] | Task force report on scales to assess dyskinesia in Parkinson's disease: Critique and recommendations |
000536 |
Jerrold L. Vitek [États-Unis] ; Kelly E. Lyons [États-Unis] ; Roy Bakay [États-Unis] ; Alim-Louis Benabid [France] ; Guenther Deuschl [Allemagne] ; Mark Hallett [États-Unis] ; Roger Kurlan [États-Unis] ; Joseph J. Pancrazio [États-Unis] ; Ali Rezai [États-Unis] ; Benjamin L. Walter [États-Unis] ; Anthony E. Lang [Canada] | Standard guidelines for publication of deep brain stimulation studies in Parkinson's disease (Guide4DBS‐PD) |
000539 |
Joaquim J. Ferreira [Portugal] ; Dulce Neutel [Portugal] ; Tiago Mestre [Portugal] ; Miguel Coelho [Portugal] ; Mário M. Rosa [Portugal] ; Olivier Rascol [France] ; Cristina Sampaio [Portugal] | Skin cancer and Parkinson's disease |
000548 |
Birgit Högl [Autriche] ; Isabelle Arnulf [France] ; Cynthia Comella [États-Unis] ; Joaquim Ferreira [Portugal] ; Alex Iranzo [Espagne] ; Barbara Tilley [États-Unis] ; Claudia Trenkwalder [Allemagne] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Cristina Sampaio [Portugal] ; Glenn T. Stebbins [États-Unis] ; Anette Schrag [Royaume-Uni] ; Christopher G. Goetz [États-Unis] | Scales to assess sleep impairment in Parkinson's disease: Critique and recommendations |
000549 |
Karla Eggert [Allemagne] ; David Squillacote [États-Unis] ; Paolo Barone [Italie] ; Richard Dodel [Allemagne] ; Regina Katzenschlager [Autriche] ; Murat Emre [Turquie] ; Andrew Lees (neurologue) [Royaume-Uni] ; Olivier Rascol [France] ; Werner Poewe [Autriche] ; Eduardo Tolosa [Espagne] ; Claudia Trenkwalder [Allemagne] ; Marco Onofrj [Italie] ; Fabrizio Stocchi [Italie] ; Giuseppe Nappi [Italie] ; Vladimir Kostic [Serbie] ; Jagoda Potic [Serbie] ; Evzen Ruzicka [République tchèque] ; Wolfgang Oertel [Allemagne] | Safety and efficacy of perampanel in advanced Parkinson's disease: A randomized, placebo‐controlled study |
000567 |
Anthony H. V. Schapira [Royaume-Uni] ; Stefan Albrecht [Allemagne] ; Paolo Barone [Italie] ; Cynthia L. Comella [États-Unis] ; Michael P. Mcdermott [États-Unis] ; Yoshikuni Mizuno [Japon] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Kenneth Marek [États-Unis] | Rationale for delayed‐start study of pramipexole in Parkinson's disease: The PROUD study |
000569 |
Robert A. Hauser [États-Unis] ; Anthony H. V. Schapira [Royaume-Uni] ; Olivier Rascol [France] ; Paolo Barone [Italie] ; Yoshikuni Mizuno [Japon] ; Laurence Salin [France] ; Monika Haaksma [Autriche] ; Nolwenn Juhel [France] ; Werner Poewe [Autriche] | Randomized, double‐blind, multicenter evaluation of pramipexole extended release once daily in early Parkinson's disease |
000599 |
Kathy Dujardin [France] ; Bruno Dubois [France] ; François Tison [France] ; Franck Durif [France] ; Isabelle Bourdeix [France] ; Jean-Jacques Péré [France] ; Alain Duhamel [France] | Parkinson's disease dementia can be easily detected in routine clinical practice |
000605 |
Tiphaine Rouaud [France] ; Thibaut Dondaine [France] ; Sophie Drapier [France] ; Claire Haegelen [France] ; François Lallement [France] ; Julie Péron [France] ; Sylvie Raoul [France] ; Paul Sauleau [France] ; Marc Vérin [France] | Pallidal stimulation in advanced Parkinson's patients with contraindications for subthalamic stimulation |
000611 |
Olivier Rascol [France] ; Jean-Philippe Azulay [France] ; Olivier Blin [France] ; Anne-Marie Bonnet [France] ; Christine Brefel-Courbon [France] ; Pierre Césaro [France] ; Philippe Damier [France] ; Bérengère Debilly [France] ; Frank Durif [France] ; Monique Galitzky [France] ; Jean-Marie Grouin [France] ; Sylvie Pennaforte [France] ; Gabriel Villafane [France] ; Sadek Yaici [France] ; Yves Agid [France] | Orodispersible sublingual piribedil to abort OFF episodes: A single dose placebo‐controlled, randomized, double‐blind, cross‐over study |
000619 |
Arnaud Delval [France, Pays-Bas] ; Anke H. Snijders [Pays-Bas] ; Vivian Weerdesteyn [Pays-Bas] ; Jacques E. Duysens [Pays-Bas] ; Luc Defebvre [France] ; Nir Giladi [Israël] ; Bastiaan R. Bloem [Pays-Bas] | Objective detection of subtle freezing of gait episodes in Parkinson's disease |
000622 |
Evangelos Evangelou [Grèce, Suisse] ; Demetrius M. Maraganore [États-Unis] ; Grazia Annesi [Italie] ; Laura Brighina [Italie] ; Alexis Brice [France] ; Alexis Elbaz [France] ; Carlo Ferrarese [Italie] ; Georgios M. Hadjigeorgiou [Grèce] ; Rejko Krueger [Allemagne] ; Jean-Charles Lambert [France] ; Suzanne Lesage [France] ; Katerina Markopoulou [Grèce] ; George D. Mellick [Australie] ; Bram Meeus [Belgique] ; Nancy L. Pedersen [Suède] ; Aldo Quattrone [Italie] ; Christine Van Broeckhoven [Belgique] ; Manu Sharma [Allemagne] ; Peter A. Silburn [Australie] ; Eng-King Tan [Singapour] ; Karin Wirdefeldt [Suède] ; John P. A. Ioannidis [Grèce, États-Unis] | Non‐replication of association for six polymorphisms from meta‐analysis of genome‐wide association studies of Parkinson's disease: Large‐scale collaborative study |
000649 |
Daniella Rylander [Suède] ; Martin Parent [Canada] ; Sean S. O'Sullivan [Royaume-Uni] ; Sandra Dovero [France] ; Andrew Lees (neurologue) [Royaume-Uni] ; Erwan Bezard [France] ; Laurent Descarries [Canada] ; M. Angela Cenci [Suède] | Maladaptive plasticity of serotonin axon terminals in levodopa‐induced dyskinesia |
000668 |
Fabrizio Stocchi [Italie] ; Olivier Rascol [France] ; Karl Kieburtz [États-Unis] ; Werner Poewe [Autriche] ; Joseph Jankovic [États-Unis] ; Eduardo Tolosa [Espagne] ; Paulo Barone [Italie] ; Anthony E. Lang [Canada] ; C. Warren Olanow [Italie, États-Unis] | Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: The STRIDE‐PD study |
000699 |
Peter Redgrave [Royaume-Uni] ; Manuel Rodriguez [Espagne] ; Yoland Smith [États-Unis] ; Maria C. Rodriguez-Oroz [Espagne] ; Stephane Lehericy [France] ; Hagai Bergman [Israël] ; Yves Agid [France] ; Mahlon R. Delong [États-Unis] ; Jose A. Obeso [Espagne] | Goal-directed and habitual control in the basal ganglia: implications for Parkinson's disease |
000714 |
Joseph H. Friedman [États-Unis] ; Guido Alves [Norvège] ; Peter Hagell [Suède] ; Johan Marinus [Pays-Bas] ; Laura Marsh [États-Unis] ; Pablo Martinez-Martin [Espagne] ; Christopher G. Goetz [États-Unis] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Cristina Sampaio [Portugal] ; Glenn Stebbins [États-Unis] ; Anette Schrag [Royaume-Uni] | Fatigue rating scales critique and recommendations by the Movement Disorders Society task force on rating scales for Parkinson's disease |
000732 |
Olivier Rascol [France] ; Paolo Barone [Italie] ; Robert A. Hauser [États-Unis] ; Yoshikuni Mizuno [Japon] ; Werner Poewe [Autriche] ; Anthony H. V. Schapira [Royaume-Uni] ; Laurence Salin [France] ; Mandy Sohr [Allemagne] ; Catherine Debieuvre [France] | Efficacy, safety, and tolerability of overnight switching from immediate‐ to once daily extended‐release pramipexole in early Parkinson's disease |
000737 |
Olivier Godefroy [France] ; Philippe Azouvi [France] ; Philippe Robert [France] ; Martine Roussel [France] ; Didier Legall [France] ; Thierry Meulemans [Belgique] | Dysexecutive syndrome: Diagnostic criteria and validation study |
000738 |
Juliana Bronzova [Pays-Bas] ; Cristina Sampaio [Portugal] ; Robert A. Hauser [États-Unis] ; Anthony E. Lang [Canada] ; Olivier Rascol [France] ; Ad Theeuwes [Pays-Bas] ; Serge V. Van De Witte [Pays-Bas] ; Guus Van Scharrenburg [Pays-Bas] | Double‐blind study of pardoprunox, a new partial dopamine agonist, in early Parkinson's disease |
000741 |
David Devos [France] ; L. Defebvre [France] ; R. Bordet [France] | Dopaminergic and non‐dopaminergic pharmacological hypotheses for gait disorders in Parkinson’s disease |
000755 |
Arjan W. Braam [Pays-Bas] ; Aartjan T. F. Beekman [Pays-Bas] ; Michael E. Dewey [Royaume-Uni] ; Philippe A. E. G. Delespaul [Pays-Bas] ; Manfred Fichter [Allemagne] ; Antonio Lobo [Espagne] ; Hallgrímur Magnússon [Islande] ; Karine Pérès [France] ; Friedel M. Reischies [Allemagne] ; Marc Roelands [Belgique] ; Pedro Saz [Espagne] ; Robert A. Schoevers [Pays-Bas] ; Ingmar Skoog [Suède] ; John R. M. Copeland [Royaume-Uni] | Depression and parkinsonism in older Europeans: results from the EURODEP concerted action |
000830 |
Lukasz Szumowski [Pologne] ; Ewa Szufladowicz [Pologne] ; Michał Orczykowski [Pologne] ; Robert Bodalski [Pologne] ; Paweł Derejko [Pologne] ; Andrzej Przybylski [Pologne] ; Piotr Urbanek [Pologne] ; Mariusz Ku Mierczyk [Pologne] ; Edward Ko Luk [Pologne] ; Frederic Sacher [France] ; Prashanthan Sanders [Australie] ; Joanna Dangel [Pologne] ; Michel Haissaguerre [France] ; Franciszek Walczak [Pologne] | Ablation of Severe Drug‐Resistant Tachyarrhythmia During Pregnancy |
000839 |
François Vacherot [France] ; Shahram Attarian [France] ; Marianne Vaugoyeau [France] ; Jean-Philippe Azulay [France] | A motor cortex excitability and gait analysis on Parkinsonian patients |
000860 |
Samareh Azeredo Da Silveira ; Bernard L. Schneider ; Carmen Cifuentes-Diaz [France] ; Daniel Sage ; Toufik Abbas-Terki ; Takeshi Iwatsubo ; Michal Unser [France] ; Patrick Aebischer [Suisse] | Phosphorylation does not prompt, nor prevent, the formation of -synuclein toxic species in a rat model of Parkinson's disease |
000862 |
Suzanne Lesage ; Alexis Brice [France] | Parkinson's disease: from monogenic forms to genetic susceptibility factors |
000891 |
M. U. Ferraye [France] ; B. Deb [France] ; V. Fraix [France] ; L. Goetz [France] ; C. Ardouin [France] ; J. Yelnik [France] ; C. Henry-Lagrange [France] ; E. Seigneuret [France] ; B. Piallat [France] ; P. Krack [France] ; J.-F. Le Bas [France] ; Alim-Louis Benabid [France] ; S. Chabards [France] ; Pierre Pollak [France] | Effects of pedunculopontine nucleus area stimulation on gait disorders in Parkinson's disease |
000896 |
Stéphanie Cantiniaux [France] ; Marianne Vaugoyeau [France] ; Danièle Robert [France] ; Christine Horrelou-Pitek [France] ; Julien Mancini [France] ; Tatiana Witjas [France] ; Jean-Philippe Azulay [France] | Comparative analysis of gait and speech in Parkinson's disease: hypokinetic or dysrhythmic disorders? |
000912 |
David A. Price [États-Unis] ; Alex A. Martinez [États-Unis] ; Alexandre Seillier [États-Unis] ; Wouter Koek [États-Unis] ; Yolanda Acosta [États-Unis] ; Elizabeth Fernandez [États-Unis] ; Randy Strong [États-Unis] ; Beat Lutz [Allemagne] ; Giovanni Marsicano [France] ; James L. Roberts [États-Unis] ; Andrea Giuffrida [États-Unis] | WIN55,212‐2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine mouse model of Parkinson’s disease |
000915 |
Nir Giladi [Israël] ; Joseph Tal [Israël] ; Tali Azulay [Israël] ; Olivier Rascol [France] ; David J. Brooks [Royaume-Uni] ; Eldad Melamed [Israël] ; Wolfgang Oertel [Allemagne] ; Werner Poewe [Autriche] ; Fabrizio Stocchi [Italie] ; Eduardo Tolosa [Espagne] | Validation of the freezing of gait questionnaire in patients with Parkinson's disease |
000927 |
Cristine Alves Da Costa [France] ; Claire Sunyach [France] ; Emilie Giaime [France] ; Andrew West [États-Unis] ; Olga Corti [France] ; Alexis Brice [France] ; Stephen Safe [États-Unis] ; Patrick M. Abou-Sleiman [Royaume-Uni] ; Nicholas W. Wood [Royaume-Uni] ; Hitoshi Takahashi [Japon] ; Mathew S. Goldberg [États-Unis] ; Jie Shen [États-Unis] ; Frdric Checler [France] | Transcriptional repression of p53 by parkin and impairment by mutations associated with autosomal recessive juvenile Parkinson's disease |
000931 |
Thibaud Lebouvier [France] ; Tanguy Chaumette [France] ; Sébastien Paillusson [France] ; Charles Duyckaerts [France] ; Stanislas Bruley Des Varannes [France] ; Michel Neunlist [France] ; Pascal Derkinderen [France] | The second brain and Parkinson’s disease |
000947 |
A. C. Ludolph [Allemagne] ; J. Kassubek [Allemagne] ; B. G. Landwehrmeyer [Allemagne] ; E. Mandelkow [Allemagne] ; E. Mandelkow [Allemagne] ; D. J. Burn [Royaume-Uni] ; D. Caparros-Lefebvre [France] ; K. A. Frey [États-Unis] ; J. G. De Yebenes [Espagne] ; T. Gasser [Allemagne] ; P. Heutink [Pays-Bas] ; G. Höglinger [Allemagne] ; Z. Jamrozik [Pologne] ; K. A. Jellinger [Autriche] ; A. Kazantsev [États-Unis] ; H. Kretzschmar [Allemagne] ; A. E. Lang [Canada] ; I. Litvan [États-Unis] ; J. J. Lucas [Espagne] ; P. L. Mcgeer [Canada] ; S. Melquist [États-Unis] ; W. Oertel [Allemagne] ; M. Otto [Allemagne] ; D. Paviour [Royaume-Uni] ; T. Reum [Allemagne] ; A. Saint-Raymond [Royaume-Uni] ; J. C. Steele ; M. Tolnay [Suisse] ; H. Tumani [Allemagne] ; J. C. Van Swieten [Pays-Bas] ; M. T. Vanier [France] ; J. Vonsattel [États-Unis] ; S. Wagner [Allemagne] ; Z. K. Wszolek [États-Unis] | Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options |
000953 |
T. D. H Lbig [France, États-Unis] ; W. Tse [États-Unis] ; P. G. Frisina [États-Unis] ; B. R. Baker [États-Unis] ; E. Hollander [États-Unis] ; H. Shapiro [États-Unis] ; M. Tagliati [États-Unis] ; W. C. Koller [États-Unis] ; C. W. Olanow [États-Unis] | Subthalamic deep brain stimulation and impulse control in Parkinson’s disease |
000955 |
Benedicte Ballanger [Canada] ; Thilo Van Eimeren [Canada] ; Elena Moro [Canada] ; Andres M. Lozano [Canada] ; Clement Hamani [Canada] ; Philippe Boulinguez [France] ; Giovanna Pellecchia [Canada] ; Sylvain Houle [Canada] ; Yu Yan Poon [Canada] ; Anthony E. Lang [Canada] ; Antonio P. Strafella [Canada] | Stimulation of the subthalamic nucleus and impulsivity: Release your horses |
000967 |
Nadège Limousin [France] ; Eric Konofal [France] ; Elias Karroum [France] ; Ebba Lohmann [France] ; Ioannis Theodorou [France] ; Alexandra Dürr [France] ; Isabelle Arnulf [France] | Restless legs syndrome, rapid eye movement sleep behavior disorder, and hypersomnia in patients with two parkin mutations |
000984 |
Alexis Elbaz [France] ; Jacqueline Clavel [France] ; Paul J. Rathouz [États-Unis] ; Frédéric Moisan [France] ; Jean-Philippe Galanaud [France] ; Bernard Delemotte [France] ; Annick Alpérovitch [France] ; Christophe Tzourio [France] | Professional exposure to pesticides and Parkinson disease |
000994 |
A. H. Schapira [Royaume-Uni] ; Yves Agid [France] ; P. Barone [Italie] ; P. Jenner [Royaume-Uni] ; M. R. Lemke [Allemagne] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; H. Reichmann [Allemagne] ; E. Tolosa [Espagne] | Perspectives on recent advances in the understanding and treatment of Parkinson’s disease |
000996 |
David Devos [France] | Patient profile, indications, efficacy and safety of duodenal levodopa infusion in advanced Parkinson's disease |
000A00 |
Ichraf Kraoua [France] ; Jérôme Stirnemann [France] ; Maria João Ribeiro [France] ; Tiphaine Rouaud [France] ; Marc Verin [France] ; Agnès Annic [France] ; Christian Rose [France] ; Luc Defebvre [France] ; Liliane Réménieras [France] ; Michaël Schüpbach [France] ; Nadia Belmatoug [France] ; Marie Vidailhet [France] ; Frédéric Sedel [France] | Parkinsonism in Gaucher's disease type 1: Ten new cases and a review of the literature |
000A09 |
S. Bannier [France] ; C. Montaurier [France] ; P P Derost [France] ; M. Ulla [France] ; J-J Lemaire [France] ; Y. Boirie [France] ; B. Morio [France] ; F. Durif [France] | Overweight after deep brain stimulation of the subthalamic nucleus in Parkinson disease: long term follow-up |
000A15 |
J. Coste [France] ; L. Ouchchane [France] ; L. Sarry [France] ; P. Derost [France] ; F. Durif [France] ; J. Gabrillargues [France] ; S. Hemm [France] ; J. J. Lemaire [France] | New electrophysiological mapping combined with MRI in parkinsonian’s subthalamic region |
000A23 |
Mélissa Tir [France] ; Christine Delmaire [France] ; Vianney Le Thuc [France] ; Alain Duhamel [France] ; Alain Destée [France] ; Jean-Pierre Pruvo [France] ; Luc Defebvre [France] | Motor‐related circuit dysfunction in MSA‐P: Usefulness of combined whole‐brain imaging analysis |
000A30 |
S. Lesage [France] ; C. Condroyer [France] ; A. Lannuzel [France] ; E. Lohmann [France] ; A. Troiano [France] ; F. Tison [France] ; P. Damier [France] ; S. Thobois [France] ; A-M Ouvrard-Hernandez [France] ; S. Rivaud-Péchoux [France] ; C. Brefel-Courbon [France] ; A. Destée [France] ; C. Tranchant [France] ; M. Romana ; L. Leclere [France] ; A. Dürr [France] ; A. Brice [France] | Molecular analyses of the LRRK2 gene in European and North African autosomal dominant Parkinson’s disease |
000A34 |
David Maltête [France] ; Nathalie Chastan [France] ; Stéphane Derrey [France] ; Bertrand Debono [France] ; Emmanuel Gérardin [France] ; Romain Lefaucheur [France] ; Bruno Mihout [France] ; Didier Hannequin [France] | Microsubthalamotomy effect at day 3: Screening for determinants |
000A45 |
Jens Volkmann [Allemagne] ; Alberto Albanese [Italie] ; Jaime Kulisevsky [Espagne] ; Aana-Lena Tornqvist [Suède] ; Jean-Luc Houeto [France] ; Bernard Pidoux [France] ; Anne-Marie Bonnet [France] ; Alexandre Mendes [France] ; Alim-Louis Benabid [France] ; Valerie Fraix [France] ; Nadege Van Blercom [France] ; Jing Xie [France] ; José Obeso [Espagne] ; Maria Cruz Rodriguez-Oroz [Espagne] ; Jurge Guridi [Espagne] ; Alfons Schnitzler [Allemagne] ; Lars Timmermann [Allemagne] ; Alexandre A. Gironell [Espagne] ; Juan Molet [Espagne] ; Benta Pascual-Sedano [Espagne] ; Stig Rehncrona [Suède] ; Elena Moro [Canada] ; Anthony C. Lang [Canada] ; Andres M. Lozano [Canada] ; Anna Rita Bentivoglio [Italie] ; Massimo Scerrati [Italie] ; Maria Fiorella Contarino [Pays-Bas] ; Luigi Romito [Italie] ; Marc Janssens [Pays-Bas] ; Yves Agid [France] | Long‐term effects of pallidal or subthalamic deep brain stimulation on quality of life in Parkinson's disease |
000B05 |
H. F. Harbo [Norvège] ; J. Finsterer [Autriche] ; J. Baets [Belgique] ; C. Van Broeckhoven [Belgique] ; S. Di Donato [Italie] ; B. Fontaine [France] ; P. De Jonghe [Belgique] ; A. Lossos [Israël] ; T. Lynch [Irlande (pays)] ; C. Mariotti [Italie] ; L. Schöls [Allemagne] ; A. Spinazzola [Italie] ; Z. Szolnoki [Hongrie] ; S. J. Tabrizi [Royaume-Uni] ; C. Tallaksen [Norvège] ; M. Zeviani [Italie] ; J. Burgunder [Suisse] ; T. Gasser [Allemagne] | EFNS guidelines on the molecular diagnosis of neurogenetic disorders: general issues, Huntington’s disease, Parkinson’s disease and dystonias |
000B06 |
Marian L. Evatt [États-Unis] ; K. Ray Chaudhuri [Royaume-Uni] ; Kelvin L. Chou [États-Unis] ; Ester Cubo [Espagne] ; Vanessa Hinson [États-Unis] ; Katie Kompoliti [États-Unis] ; Chengwu Yang [États-Unis] ; Werner Poewe [États-Unis] ; Olivier Rascol [Autriche] ; Cristina Sampaio [France, Portugal] ; Glenn T. Stebbins [États-Unis] ; Christopher G. Goetz [États-Unis] | Dysautonomia rating scales in Parkinson's disease: Sialorrhea, dysphagia, and constipation—Critique and recommendations by movement disorders task force on rating scales for Parkinson's disease |
000B15 |
Nadja Van Camp [Belgique, France] ; Ines Blockx [Belgique] ; Marleen Verhoye [Belgique] ; Cindy Casteels [Belgique] ; Frea Coun [Belgique] ; Alexander Leemans [Royaume-Uni, Pays-Bas] ; Jan Sijbers [Belgique] ; Veerle Baekelandt [Belgique] ; Koen Van Laere [Belgique] ; Annemie Van Der Linden [Belgique] | Diffusion tensor imaging in a rat model of Parkinson's disease after lesioning of the nigrostriatal tract |
000B32 |
Gabriel Robert [France] ; Dominique Drapier [France] ; Marc Verin [France] ; Bruno Millet [France] ; Jean-Philippe Azulay [France] ; Olivier Blin [France] | Cognitive impulsivity in Parkinson's disease patients: Assessment and pathophysiology |
000B64 |
Dennis A. Nowak [Allemagne, États-Unis] ; Mitra Ameli [Allemagne] ; Friederike Kemper [Allemagne] ; Anna-Sophia Sarfeld [Allemagne] ; Djamel Bensmail [Allemagne, France] ; Jürgen Konczak [États-Unis] ; Gereon R. Fink [Allemagne] | Arbitrary visuomotor mapping during object manipulation in Parkinson's disease |
000B65 |
Kathy Dujardin [France] ; Pascal Sockeel [France] ; Marie Delliaux [France] ; Alain Destée [France] ; Luc Defebvre [France] | Apathy may herald cognitive decline and dementia in Parkinson's disease |
000B72 |
Donald Grosset [Royaume-Uni] ; Angelo Antonini [Italie] ; Margherita Canesi [Italie] ; Gianni Pezzoli [Italie] ; Andrew Lees (neurologue) [Royaume-Uni] ; Karen Shaw [Royaume-Uni] ; Esther Cubo [Espagne] ; Pablo Martinez-Martin [Espagne] ; Olivier Rascol [France] ; Laurence Negre-Pages [France] ; Ana Senard [France] ; Johannes Schwarz [Allemagne] ; Karl Strecker [Allemagne] ; Heinz Reichmann [Allemagne] ; Alexander Storch [Allemagne] ; Matthias Löhle [Allemagne] ; Fabrizio Stocchi [Italie] ; Katherine Grosset [Royaume-Uni] | Adherence to antiparkinson medication in a multicenter European study |
000B83 |
Olivier Rascol [France] ; Ludwig Schelosky [Suisse] | 123I‐metaiodobenzylguanidine scintigraphy in Parkinson's disease and related disorders |
000B99 |
N. Chastan [France] ; G. W. M. Westby [France] ; J. Yelnik [France] ; E. Bardinet [France] ; M. C. Do [France] ; Yves Agid [France] ; M. L. Welter [France] | Effects of nigral stimulation on locomotion and postural stability in patients with Parkinson's disease |
000C07 |
Ana Mu Oz [France] ; Qin Li [France] ; Fabrizio Gardoni [France] ; Elena Marcello [France] ; Chuan Qin [France] ; Thomas Carlsson [France] ; Deniz Kirik [France] ; Monica Di Luca [France] ; Anders Björklund [France] ; Erwan Bezard [France, Suède] ; Manolo Carta [France, Suède] | Combined 5-HT1A and 5-HT1B receptor agonists for the treatment of l-DOPA-induced dyskinesia |
000C12 |
Julien Chapuis ; Frdric Moisan ; Georges Mellick ; Alexis Elbaz ; Peter Silburn ; Florence Pasquier ; Didier Hannequin [France] ; Corinne Lendon ; Dominique Campion [France] ; Philippe Amouyel ; Jean-Charles Lambert [France] | Association study of the NEDD9 gene with the risk of developing Alzheimer's and Parkinson's disease |
000C51 |
Andrew Lees (neurologue) [Royaume-Uni] ; Marianna Selikhova [Royaume-Uni] ; Luiz Augusto Andrade [Brésil] ; Charles Duyckaerts [France] | The black stuff and Konstantin Nikolaevich Tretiakoff |
000C73 |
Hubert H. Fernandez [États-Unis] ; Dag Aarsland [Norvège] ; Gilles Fénelon [France] ; Joseph H. Friedman [États-Unis] ; Laura Marsh [États-Unis] ; Alexander I. Tröster [États-Unis] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Cristina Sampaio [Portugal] ; Glenn T. Stebbins [États-Unis] ; Christopher G. Goetz [États-Unis] | Scales to assess psychosis in Parkinson's disease: Critique and recommendations |
000C77 |
Jean-Sébastien Vidal [France] ; Marie Vidailhet [France] ; Alexis Elbaz [France] ; Pascal Derkinderen [France] ; Christophe Tzourio [France] ; Annick Alpérovitch [France] | Risk factors of multiple system atrophy: A case‐control study in French patients |
000C83 |
S. Lesage [France] ; E. Lohmann [France] ; F. Tison [France] ; F. Durif [France] ; A. Dürr [France] ; A. Brice [France] | Rare heterozygous parkin variants in French early-onset Parkinson disease patients and controls |
000D15 |
Christopher G. Goetz [États-Unis] ; Murat Emre [Turquie] ; Bruno Dubois [France] | Parkinson's disease dementia: Definitions, guidelines, and research perspectives in diagnosis |
000D49 |
David Maltête [France] ; Stéphane Derrey [France] ; Nathalie Chastan [France] ; Bertrand Debono [France] ; Emmanuel Gérardin [France] ; Pierre Fréger [France] ; Bruno Mihout [France] ; Jean François Menard [France] ; Didier Hannequin [France] | Microsubthalamotomy: An immediate predictor of long‐term subthalamic stimulation efficacy in Parkinson disease |
000D62 |
P. Damier [France] ; F. Viallet [France] ; M. Ziegler [France] ; I. Bourdeix [France] ; K. Rerat [France] | Levodopa/DDCI and entacapone is the preferred treatment for Parkinson’s disease patients with motor fluctuations in routine practice: a retrospective, observational analysis of a large French cohort |
000D89 |
Owen A. Ross [États-Unis] ; Adam T. Braithwaite [États-Unis] ; Lisa M. Skipper [États-Unis] ; Jennifer Kachergus [États-Unis] ; Mary M. Hulihan [États-Unis] ; Frank A. Middleton [États-Unis] ; Kenya Nishioka [Japon] ; Julia Fuchs [Allemagne] ; Thomas Gasser [Allemagne] ; Demetrius M. Maraganore [États-Unis] ; Charles H. Adler [États-Unis] ; Lydie Larvor [France] ; Marie-Christine Chartier-Harlin [France] ; Christer Nilsson [Suède] ; J. William Langston [États-Unis] ; Katrina Gwinn [États-Unis] ; Nobutaka Hattori [Japon] ; Matthew J. Farrer [États-Unis] | Genomic investigation of α‐synuclein multiplication and parkinsonism |
000E24 |
Werner Poewe [Autriche] ; S. Gauthier [Canada] ; D. Aarsland [Norvège] ; J. B. Leverenz [États-Unis] ; P. Barone [Italie] ; D. Weintraub [États-Unis] ; E. Tolosa [Espagne] ; B. Dubois [France] | Diagnosis and management of Parkinson’s disease dementia |
000E29 |
Murielle U. Ferraye [France] ; Bettina Debû [France] ; Pierre Pollak [France] | Deep brain stimulation effect on freezing of gait |
000E38 |
David Devos [France] ; Kathy Dujardin [France] ; Isabelle Poirot [France] ; Caroline Moreau [France] ; Olivier Cottencin [France] ; Pierre Thomas [France] ; Alain Destée [France] ; Regis Bordet [France] ; Luc Defebvre [France] | Comparison of desipramine and citalopram treatments for depression in Parkinson's disease: A double‐blind, randomized, placebo‐controlled study |
000E48 |
Laurence Nègre-Pagès [France] ; Wafa Regragui [Maroc] ; Didier Bouhassira [France] ; Héléne Grandjean [France] ; Olivier Rascol [France] | Chronic pain in Parkinson's disease: The cross‐sectional French DoPaMiP survey |
000E66 |
Virginie Czernecki [France] ; Michael Schüpbach [France, Suisse] ; Sadek Yaici [France] ; Richard Lévy [France] ; Eric Bardinet [France] ; Jérôme Yelnik [France] ; Bruno Dubois [France] ; Yves Agid [France] | Apathy following subthalamic stimulation in Parkinson disease: A dopamine responsive symptom |
000E67 |
Albert F. G. Leentjens [Pays-Bas] ; Kathy Dujardin [France] ; Laura Marsh [États-Unis] ; Pablo Martinez-Martin [Espagne] ; Irene H. Richard [États-Unis] ; Sergio E. Starkstein [Australie] ; Daniel Weintraub [États-Unis] ; Cristina Sampaio [Portugal] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Glenn T. Stebbins [États-Unis] ; Christopher G. Goetz [États-Unis] | Apathy and anhedonia rating scales in Parkinson's disease: Critique and recommendations |
000E68 |
Albert F. G. Leentjens [Pays-Bas] ; Kathy Dujardin [France] ; Laura Marsh [États-Unis] ; Pablo Martinez-Martin [Espagne] ; Irene H. Richard [États-Unis] ; Sergio E. Starkstein [Australie] ; Daniel Weintraub [États-Unis] ; Christina Sampaio [Portugal] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Glenn T. Stebbins [États-Unis] ; Christopher G. Goetz [États-Unis] | Anxiety rating scales in Parkinson's disease: Critique and recommendations |
000E78 |
C. Warren Olanow [États-Unis] ; Robert A. Hauser [États-Unis] ; Joseph Jankovic [États-Unis] ; William Langston [États-Unis] ; Anthony Lang [Canada] ; Werner Poewe [Autriche] ; Eduardo Tolosa [Espagne] ; Fabrizio Stocchi [Italie] ; Eldad Melamed [Israël] ; Eli Eyal [Israël] ; Olivier Rascol [France] | A randomized, double‐blind, placebo‐controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson's disease (the ADAGIO study): Rationale, design, and baseline characteristics |
000F11 |
Stéphanie Mounayar [France] ; Sabrina Boulet [France] ; Dominique Tandé [France] ; Caroline Jan [France] ; Mathias Pessiglione [France] ; Etienne C. Hirsch [France] ; Jean Féger [France] ; Marc Savasta [France] ; Chantal François [France] ; Léon Tremblay [France] | A new model to study compensatory mechanisms in MPTP-treated monkeys exhibiting recovery |
000F43 |
Robert A. Hauser [États-Unis] ; Olivier Rascol [France] ; Amos D. Korczyn [Israël] ; A. Jon Stoessl [Canada] ; Ray L. Watts [États-Unis] ; Werner Poewe [Autriche] ; Peter P. De Deyn [Belgique] ; Anthony E. Lang [Canada] | Ten‐year follow‐up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa |
000F64 |
Valérie Cochen De Cock [France] ; Marie Vidailhet [France] ; Smaranda Leu [France] ; Antonio Texeira [France] ; Emmanuelle Apartis [France] ; Alexis Elbaz [France] ; Emmanuel Roze [France] ; Jean Claude Willer [France] ; Jean Philippe Derenne [France] ; Yves Agid [France] ; Isabelle Arnulf [France] | Restoration of normal motor control in Parkinson's disease during REM sleep |
000F68 |
G. Waldemar [Danemark] ; B. Dubois [France] ; M. Emre [Turquie] ; J. Georges [Luxembourg (pays)] ; I. G. Mckeith [Royaume-Uni] ; M. Rossor [Royaume-Uni] ; P. Scheltens [Pays-Bas] ; P. Tariska [Hongrie] ; B. Winblad [Suède] | Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline |
000F70 |
Vincent Paillé [France] ; Vincent Henry [France] ; Laurent Lescaudron [France] ; Philippe Brachet [France] ; Philippe Damier [France] | Rat model of Parkinson's disease with bilateral motor abnormalities, reversible with levodopa, and dyskinesias |
001003 |
Julie Deguil [France] ; David Jailloux [France] ; Guylène Page [France] ; Bernard Fauconneau [France] ; Jean-Luc Houeto [France] ; Michel Philippe [France] ; Jean-Marc Muller [France] ; Stéphanie Pain [France] | Neuroprotective effects of pituitary adenylate cyclase–activating polypeptide (PACAP) in MPP+‐induced alteration of translational control in Neuro‐2a neuroblastoma cells |
001006 |
Smaranda Leu-Semenescu [France] ; Emmanuel Roze [France] ; Marie Vidailhet [France] ; André-Pierre Legrand [France] ; Jean-Marc Trocello [France] ; Valérie Cochen [France] ; Sophie Sangla [France] ; Emmanuelle Apartis [France] | Myoclonus or tremor in orthostatism: An under‐recognized cause of unsteadiness in Parkinson's disease |
001007 |
Michael W. M. Schüpbach [France] ; Marie Laure Welter [France] ; Anne Marie Bonnet [France] ; Alexis Elbaz [France] ; Brandon R. Grossardt [États-Unis] ; Valerie Mesnage [France] ; Jean Luc Houeto [France] ; David Maltête [France] ; Luc Mallet [France] ; Walter A. Rocca [États-Unis] ; Alain Mallet [France] ; Yves Agid [France] | Mortality in patients with Parkinson's disease treated by stimulation of the subthalamic nucleus |
001040 |
Emilie Lacombe ; Carole Carcenac ; Sabrina Boulet ; Claude Feuerstein [France] ; Anne Bertrand ; Annie Poupard ; Marc Savasta [France] | High‐frequency stimulation of the subthalamic nucleus prolongs the increase in striatal dopamine induced by acute l‐3,4‐dihydroxyphenylalanine in dopaminergic denervated rats |
001062 |
Tatiana Witjas [France] ; Elsa Kaphan [France] ; Jean Régis [France] ; Elisabeth Jouve [France] ; André Ali Chérif [France] ; Jean-Claude Péragut [France] ; Jean Philippe Azulay [France] | Effects of chronic subthalamic stimulation on nonmotor fluctuations in Parkinson's disease |
001070 |
Fabienne Ory-Magne [France] ; Christine Brefel-Courbon [France] ; Marion Simonetta-Moreau [France] ; Nelly Fabre [France] ; Jean Albert Lotterie [France] ; Patrick Chaynes [France] ; Isabelle Berry [France] ; Yves Lazorthes [France] ; Olivier Rascol [France] | Does ageing influence deep brain stimulation outcomes in Parkinson's disease? |
001075 |
Bruno Dubois [France] ; David Burn [Royaume-Uni] ; Christopher Goetz [États-Unis] ; Dag Aarsland [Norvège] ; Richard G. Brown [Royaume-Uni] ; Gerald A. Broe [Australie] ; Dennis Dickson [États-Unis] ; Charles Duyckaerts [France] ; Jefferey Cummings [États-Unis] ; Serge Gauthier [Canada] ; Amos Korczyn [Israël] ; Andrew Lees (neurologue) [Royaume-Uni] ; Richard Levy [France] ; Irene Litvan [États-Unis] ; Yoshikuni Mizuno [Japon] ; Ian G. Mckeith [Royaume-Uni] ; C. Warren Olanow [États-Unis] ; Werner Poewe [Autriche] ; Cristina Sampaio [Portugal] ; Eduardo Tolosa [Espagne] ; Murat Emre [Turquie] | Diagnostic procedures for Parkinson's disease dementia: Recommendations from the movement disorder society task force |
001080 |
Anette Schrag [Royaume-Uni] ; Paolo Barone [Italie] ; Richard G. Brown [Royaume-Uni] ; Albert F. G. Leentjens [Pays-Bas] ; William M. Mcdonald [États-Unis] ; Sergio Starkstein [Australie] ; Daniel Weintraub [États-Unis] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Cristina Sampaio [Portugal] ; Glenn T. Stebbins [États-Unis] ; Christopher G. Goetz [États-Unis] | Depression rating scales in Parkinson's disease: Critique and recommendations |
001083 |
Suzanne Lesage [France] ; Periquet Magali [France] ; Ebba Lohmann [France] ; Lucette Lacomblez [France] ; Helio Teive [Brésil] ; Sabine Janin [France] ; Pierre-Yves Cousin [France] ; Alexandra Dürr [France] ; Alexis Brice [France] | Deletion of the parkin and PACRG gene promoter in early‐onset parkinsonism |
001089 |
Lorraine N. Clark [États-Unis] ; Eneli Haamer [Estonie] ; Helen Mejia-Santana [États-Unis] ; Juliette Harris [États-Unis] ; Suzanne Lesage [France] ; Alexandra Durr [France] ; Sabine Janin Bs [France] ; Katja Hedrich [Allemagne] ; Elan D. Louis [États-Unis] ; Lucien J. Cote [États-Unis] ; Howard Andrews [États-Unis] ; Stanley Fahn [États-Unis] ; Cheryl Waters [États-Unis] ; Blair Ford [États-Unis] ; Steven Frucht [États-Unis] ; William Scott [États-Unis] ; Christine Klein [Allemagne] ; Alexis Brice [France] ; Hanno Roomere [Estonie] ; Ruth Ottman [États-Unis] ; Karen Marder [États-Unis] | Construction and validation of a Parkinson's disease mutation genotyping array for the Parkin gene |
001098 |
Murat Emre [Turquie] ; Dag Aarsland [Norvège] ; Richard Brown [Royaume-Uni] ; David J. Burn [Royaume-Uni] ; Charles Duyckaerts [France] ; Yoshikino Mizuno [Japon] ; Gerald Anthony Broe [Australie] ; Jeffrey Cummings [États-Unis] ; Dennis W. Dickson [États-Unis] ; Serge Gauthier [Canada] ; Jennifer Goldman [États-Unis] ; Christopher Goetz [États-Unis] ; Amos Korczyn [Israël] ; Andrew Lees (neurologue) [Royaume-Uni] ; Richard Levy [France] ; Irene Litvan [États-Unis] ; Ian Mckeith [Royaume-Uni] ; Warren Olanow [États-Unis] ; Werner Poewe [Autriche] ; Niall Quinn [Royaume-Uni] ; Christina Sampaio [Portugal] ; Eduardo Tolosa [Espagne] ; Bruno Dubois [France] | Clinical diagnostic criteria for dementia associated with Parkinson's disease |
001135 |
Imad Ghorayeb [France] ; Anderson Loundou [France] ; Pascal Auquier [France] ; Yves Dauvilliers [France] ; Bernard Bioulac [France] ; François Tison [France] | A nationwide survey of excessive daytime sleepiness in Parkinson's disease in France |
001154 |
Isabelle Le Ber [France] ; Eric Guedj [France] ; Audrey Gabelle [France] ; Patrice Verpillat [France] ; Magali Volteau [France] ; Catherine Thomas-Anterion [France] ; Marielle Decousus [France] ; Didier Hannequin [France] ; Pierre Véra [France] ; Lucette Lacomblez [France] ; Agnès Camuzat [France] ; Mira Didic [France] ; Michèle Puel [France] ; Jean-Albert Lotterie [France] ; Véronique Golfier [France] ; Anne-Marie Bernard [France] ; Martine Vercelletto [France] ; Christine Magne [France] ; François Sellal [France] ; Izzie Namer [France] ; Bernard-François Michel [France] ; Jacques Pasquier [France] ; François Salachas [France] ; Jean Bochet [France] ; Alexis Brice [France] ; Marie-Odile Habert [France] ; Bruno Dubois [France] | Demographic, neurological and behavioural characteristics and brain perfusion SPECT in frontal variant of frontotemporal dementia |
001155 |
Cornelia Hampe ; Hector Ardila-Osorio ; Margot Fournier ; Alexis Brice ; Olga Corti [France] | Biochemical analysis of Parkinson's disease-causing variants of Parkin, an E3 ubiquitinprotein ligase with monoubiquitylation capacity |
001180 |
M. Sharma [Allemagne] ; J C Mueller [Allemagne] ; A. Zimprich [Autriche] ; P. Lichtner [Allemagne] ; A. Hofer [Allemagne] ; P. Leitner [Allemagne] ; S. Maass [Allemagne] ; D. Berg [Allemagne] ; A. Dürr [France] ; V. Bonifati [Italie] ; G. De Michele [Pays-Bas] ; B. Oostra [Italie] ; A. Brice [France] ; N W Wood [Royaume-Uni] ; B. Muller-Myhsok [Allemagne] ; T. Gasser [Allemagne] | The sepiapterin reductase gene region reveals association in the PARK3 locus: analysis of familial and sporadic Parkinson’s disease in European populations |
001185 |
Alexandre Castro-Caldas [Portugal] ; Paul Delwaide [Belgique] ; Wolfgang Jost [Allemagne] ; Marcelo Merello [Argentine] ; Adrian Williams [Royaume-Uni] ; Paolo Lamberti [Italie] ; Miguel Aguilar [Espagne] ; Susanna Del Signore [France] ; Pierre Cesaro [France] | The Parkinson–Control study: A 1‐year randomized, double‐blind trial comparing piribedil (150 mg/day) with bromocriptine (25 mg/day) in early combination with levodopa in Parkinson's disease |
001193 |
Karsten Witt [Allemagne] ; Florian Kopper [Allemagne] ; Günther Deuschl [Allemagne] ; Paul Krack [France] | Subthalamic nucleus influences spatial orientation in extrapersonal space |
001202 |
D. Guehl [France] ; E. Cuny [France] ; A. Benazzouz [France] ; A. Rougier [France] ; F. Tison [France] ; S. Machado [France] ; D. Grabot [France] ; C. Gross [France] ; B. Bioulac [France] ; P. Burbaud [France] | Side‐effects of subthalamic stimulation in Parkinson's disease: clinical evolution and predictive factors |
001206 |
M. Horstink [Pays-Bas] ; E. Tolosa [Espagne] ; U. Bonuccelli [Italie] ; G. Deuschl [Allemagne] ; A. Friedman [Pologne] ; P. Kanovsky [République tchèque] ; J. P. Larsen [Norvège] ; A. Lees [Royaume-Uni] ; W. Oertel [Allemagne] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; C. Sampaio [Portugal] | Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies and the Movement Disorder Society–European Section. Part I: early (uncomplicated) Parkinson's disease |
001207 |
M. Horstink [Pays-Bas] ; E. Tolosa [Espagne] ; U. Bonuccelli [Italie] ; G. Deuschl [Allemagne] ; A. Friedman [Pologne] ; P. Kanovsky [République tchèque] ; J. P. Larsen [Norvège] ; A. Lees [Royaume-Uni] ; W. Oertel [Allemagne] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; C. Sampaio [Portugal] | Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies (EFNS) and the Movement Disorder Society‐European Section (MDS‐ES). Part II: late (complicated) Parkinson's disease |
001235 |
Wolfgang H. Oertel [Allemagne] ; Erik Wolters [Pays-Bas] ; Cristina Sampaio [Portugal] ; Santiago Gimenez-Roldan [Espagne] ; Bruno Bergamasco [Italie] ; Max Dujardin [France] ; Donald G. Grosset [Royaume-Uni] ; Guy Arnold [Allemagne] ; Klaus L. Leenders [Pays-Bas] ; Hans-Peter Hundemer [États-Unis] ; Alberto Lled [États-Unis] ; Andrew Wood [États-Unis] ; Paul Frewer [États-Unis] ; Johannes Schwarz [Allemagne] | Pergolide versus levodopa monotherapy in early Parkinson's disease patients: The PELMOPET study |
001236 |
Claire Ardouin [France] ; Valerie Voon [Canada] ; Yulia Worbe [France] ; Nehman Abouazar [France] ; Virginie Czernecki [France] ; Hassan Hosseini [France] ; Antoine Pelissolo [France] ; Elena Moro [Canada] ; Eugénie Lhommée [France] ; Anthony E. Lang [Canada] ; Yves Agid [France] ; Alim-Louis Benabid [France] ; Pierre Pollak [France] ; Luc Mallet [France] ; Paul Krack [France] | Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation |
001239 |
François Sellal [France] | Parkinson's disease with dementia and dementia with Lewy body disease: two syndromes, the same disease? |
001250 |
Anthony H. V. Schapira [Royaume-Uni] ; Erwan Bezard [France] ; Jonathan Brotchie [Canada] ; Frdric Calon [Canada] ; Graham L. Collingridge [Royaume-Uni] ; Borris Ferger [Allemagne] ; Bastian Hengerer [Allemagne] ; Etienne Hirsch [France] ; Peter Jenner [Royaume-Uni] ; Nicolas Le Novre [Royaume-Uni] ; Jos A. Obeso [Espagne] ; Michael A. Schwarzschild [États-Unis] ; Umberto Spampinato [France] ; Giora Davidai [États-Unis] | Novel pharmacological targets for the treatment of Parkinson's disease |
001257 |
Pablo Iba N Ez ; Suzanne Lesage ; Ebba Lohmann ; Ste Phane Thobois ; Giuseppe De Michele [Italie] ; Michel Borg ; Yves Agid [France] ; Alexandra Du Rr ; Alexis Brice | Mutational analysis of the PINK1 gene in early-onset parkinsonism in Europe and North Africa |
001307 |
Robert E. Gross [États-Unis] ; Paul Krack [France] ; Maria C. Rodriguez-Oroz [Espagne] ; Ali R. Rezai [États-Unis] ; Alim-Louis Benabid [France] | Electrophysiological mapping for the implantation of deep brain stimulators for Parkinson's disease and tremor |
001313 |
Aurélie Funkiewiez [France] ; Claire Ardouin [France] ; Roshan Cools [Royaume-Uni] ; Paul Krack [France] ; Valérie Fraix [France] ; Alina Batir [France] ; Stephan Chabardès [France] ; Alim-Louis Benabid [France] ; Trevor W. Robbins [Royaume-Uni] ; Pierre Pollak [France] | Effects of levodopa and subthalamic nucleus stimulation on cognitive and affective functioning in Parkinson's disease |
001317 |
Olivier Rascol [France] ; Bruno Dubois [France] ; Alexandre Castro Caldas [Portugal] ; Stephen Senn [Royaume-Uni] ; Susanna Del Signore [France] ; Andrew Lees (neurologue) [Royaume-Uni] | Early piribedil monotherapy of Parkinson's disease: A planned seven‐month report of the REGAIN study |
001322 |
Olivier Rascol [France] ; David J. Brooks [Royaume-Uni] ; Amos D. Korczyn [Israël] ; Peter P. De Deyn [Belgique] ; Carl E. Clarke [Royaume-Uni] ; Anthony E. Lang [Canada] ; Mona Abdalla [Royaume-Uni] | Development of dyskinesias in a 5‐year trial of ropinirole and L‐dopa |
001327 |
Anthony E. Lang [Canada] ; Jean-Luc Houeto [France] ; Paul Krack [France] ; Cynthia Kubu [États-Unis] ; Kelly E. Lyons [États-Unis] ; Elena Moro [Canada] ; William Ondo [États-Unis] ; Rajesh Pahwa [États-Unis] ; Werner Poewe [Autriche] ; Alexander I. Tröster [États-Unis] ; Ryan Uitti [États-Unis] ; Valerie Voon [Canada, États-Unis] | Deep brain stimulation: Preoperative issues |
001329 |
Valerie Voon [Canada, États-Unis] ; Cynthia Kubu [États-Unis] ; Paul Krack [France] ; Jean-Luc Houeto [France] ; Alexander I. Tröster [États-Unis] | Deep brain stimulation: Neuropsychological and neuropsychiatric issues |
001330 |
Ali R. Rezai [États-Unis] ; Brian H. Kopell [États-Unis] ; Robert E. Gross [États-Unis] ; Jerrold L. Vitek [États-Unis] ; Ashwini D. Sharan [États-Unis] ; Patricia Limousin [Royaume-Uni] ; Alim-Louis Benabid [France] | Deep brain stimulation for Parkinson's disease: Surgical issues |
001333 |
Shannon K. Mcdonnell [États-Unis] ; Daniel J. Schaid [États-Unis] ; Alexis Elbaz [États-Unis, France] ; Kari J. Strain [États-Unis] ; James H. Bower [États-Unis] ; J. Eric Ahlskog [États-Unis] ; Demetrius M. Maraganore [États-Unis] ; Walter A. Rocca [États-Unis] | Complex segregation analysis of Parkinson's disease: The Mayo Clinic Family Study |
001367 |
A-C Lepoutre [France] ; D. Devos [France] ; A. Blanchard-Dauphin ; V. Pardessus ; C-A Maurage ; D. Ferriby [France] ; J-F Hurtevent ; A. Cotten ; A. Destée [France] ; L. Defebvre [France] | A specific clinical pattern of camptocormia in Parkinson’s disease |
001370 |
Nicolas Pineda-Trujillo [Royaume-Uni, Colombie] ; Maria Apergi [Royaume-Uni] ; Sonia Moreno [Colombie] ; William Arias [Colombie] ; Suzanne Lesage [France] ; Alejandro Franco [Colombie] ; Diego Sepulveda-Falla [Colombie] ; David Cano [Colombie] ; Omar Buriticá [Colombie] ; David Pineda [Colombie] ; Carlos Santiago Uribe [Colombie] ; Justo Garcia De Yebenes [Espagne] ; Andrew Lees (neurologue) [Royaume-Uni] ; Alexis Brice [France] ; Gabriel Bedoya [Colombie] ; Francisco Lopera [Colombie] ; Andres Ruiz-Linares [Royaume-Uni, Colombie] | A genetic cluster of early onset Parkinson's disease in a Colombian population |
001389 |
Josiane Holstein [France] ; Florence Canoui Poitrine [France] ; Josiane Holstein [France] ; Florence Canoui Poitrine [France] ; Anke Neumann [France] ; Eric Lepage [France] ; Alfred Spira [France] ; Alfred Spira [France] | Were less disabled patients the most affected by 2003 heat wave in nursing homes in Paris, France? |
001391 |
N. Déglon [France] ; P. Hantraye [France] | Viral vectors as tools to model and treat neurodegenerative disorders |
001418 |
W M M. Schüpbach [France] ; N. Chastan [France] ; M L Welter [France] ; J L Houeto [France] ; V. Mesnage [France] ; A M Bonnet [France] ; V. Czernecki [France] ; D. Maltête [France] ; A. Hartmann [France] ; L. Mallet [France] ; B. Pidoux [France] ; D. Dormont [France] ; S. Navarro [France] ; P. Cornu [France] ; A. Mallet [France] ; Yves Agid [France] | Stimulation of the subthalamic nucleus in Parkinson’s disease: a 5 year follow up |
001426 |
Urs P. Mosimann ; Rene M. Mu Ri ; David J. Burn ; Jacques Felblinger [France] ; John T. O'Brien ; Ian G. Mckeith | Saccadic eye movement changes in Parkinson's disease dementia and dementia with Lewy bodies |
001471 |
Catharine A. Winstanley [Royaume-Uni] ; Christelle Baunez [France] ; David E. H. Theobald [Royaume-Uni] ; Trevor W. Robbins [Royaume-Uni] | Lesions to the subthalamic nucleus decrease impulsive choice but impair autoshaping in rats: the importance of the basal ganglia in Pavlovian conditioning and impulse control |
001480 |
Stéphane Chapuis [France] ; Lemlih Ouchchane [France] ; Olivier Metz [France] ; Laurent Gerbaud [France] ; Franck Durif [France] | Impact of the motor complications of Parkinson's disease on the quality of life |
001485 |
Anne Doé De Maindreville [France] ; Gilles Fénelon [France] ; Florence Mahieux [France] | Hallucinations in Parkinson's disease: A follow‐up study |
001498 |
Christopher G. Goetz [États-Unis] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Cristina Sampaio [Portugal] | Evidence‐based medical review update: Pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004 |
001499 |
M. Péchevis [France] ; C. E. Clarke [Royaume-Uni] ; P. Vieregge [Allemagne] ; B. Khoshnood [France] ; C. Deschaseaux-Voinet [France] ; G. Berdeaux [France] ; M. Ziegler [France] | Effects of dyskinesias in Parkinson's disease on quality of life and health‐related costs: a prospective European study |
001509 |
Philippe Remy [France] ; Miroslava Doder [France] ; Andrew Lees (neurologue) [Royaume-Uni, France] ; Nora Turjanski [France] ; David Brooks [France] | Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system |
001524 |
Jean-Philippe Galanaud [France] ; Alexis Elbaz [France] ; Jacqueline Clavel [France] ; Jean-Sébastien Vidal [France] ; Jean-René Corrèze [France] ; Annick Alpérovitch [France] ; Christophe Tzourio [France] | Cigarette smoking and Parkinson's disease: A case–control study in a population characterized by a high prevalence of pesticide exposure |
001526 |
Serge Pinto [France, Royaume-Uni] ; Michèle Gentil [France] ; Paul Krack [France] ; Paul Sauleau [France] ; Valérie Fraix [France] ; Alim-Louis Benabid [France] ; Pierre Pollak [France] | Changes induced by levodopa and subthalamic nucleus stimulation on parkinsonian speech |
001572 |
D. Devos ; E. Labyt ; P. Derambure ; J. L. Bourriez ; F. Cassim ; N. Reyns [France] ; S. Blond [France] ; J. D. Guieu ; A. Deste E ; L. Defebvre | Subthalamic nucleus stimulation modulates motor cortex oscillatory activity in Parkinson’s disease |
001573 |
Serge Pinto ; Ste Phane Thobois ; Nicolas Costes ; Didier Le Bars ; Alim-Louis Benabid [France] ; Emmanuel Broussolle ; Pierre Pollak [France] ; Miche Le Gentil | Subthalamic nucleus stimulation and dysarthria in Parkinson’s disease: a PET study |
001579 |
Jan C. M. Zijlmans [Royaume-Uni, Pays-Bas] ; Berengere Debilly [France] ; Olivier Rascol [France] ; Andrew Lees (neurologue) [Royaume-Uni] ; Franck Durif [France] | Safety of entacapone and apomorphine coadministration in levodopa‐treated Parkinson's disease patients: Pharmacokinetic and pharmacodynamic results of a multicenter, double‐blind, placebo‐controlled, cross‐over study |
001605 |
Christopher G. Goetz [États-Unis] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Cristina Sampaio [Royaume-Uni] ; Glenn T. Stebbins [États-Unis] ; Carl Counsell [Portugal] ; Nir Giladi [Israël] ; Robert G. Holloway [États-Unis] ; Charity G. Moore [États-Unis] ; Gregor K. Wenning [Autriche] ; Melvin D. Yahr [États-Unis] ; Lisa Seidl [États-Unis] | Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: Status and recommendations The Movement Disorder Society Task Force on rating scales for Parkinson's disease |
001613 |
C. Warren Olanow [États-Unis] ; Yves Agid [France] ; Yoshi Mizuno [Japon] ; Alberto Albanese [Italie] ; U. Bonucelli [Italie] ; Philip Damier [France] ; Justo De Yebenes [Espagne] ; Oscar Gershanik [Argentine] ; Mark Guttman [Canada] ; F. Grandas [Espagne] ; Mark Hallett [États-Unis] ; Ole Hornykiewicz [Autriche] ; Peter Jenner [Royaume-Uni] ; R. Katzenschlager [Royaume-Uni] ; William J. Langston [États-Unis] ; Peter Lewitt [États-Unis] ; Eldad Melamed [Israël] ; M. A. Mena [Espagne] ; P. P. Michel [France] ; Catherine Mytilineou [États-Unis] ; Jose A. Obeso [Espagne] ; Werner Poewe [Autriche] ; Niall Quinn [Royaume-Uni] ; R. Raisman-Vozari [France] ; Ali H. Rajput [Canada] ; Olivier Rascol [France] ; Christina Sampaio [Portugal] ; Fabrizio Stocchi [Italie] | Levodopa in the treatment of Parkinson's disease: Current controversies |
001629 |
M. Martinez [France] ; A. Brice [France] ; J R Vaughan [Royaume-Uni] ; A. Zimprich [Allemagne] ; M M B. Breteler [Pays-Bas] ; G. Meco [Italie] ; A. Filla [Italie] ; M J Farrer [États-Unis] ; C. Bétard [France] ; J. Hardy [États-Unis] ; G. De Michele [Italie] ; V. Bonifati [Italie] ; B. Oostra [Pays-Bas] ; T. Gasser [Allemagne] ; N W Wood [Royaume-Uni] ; A. Dürr [France] | Genome-wide scan linkage analysis for Parkinson’s disease: the European genetic study of Parkinson’s disease |
001637 |
Catherine Lozza [France] ; Jean-Claude Baron [France, Royaume-Uni] ; David Eidelberg [États-Unis] ; Marc J. Mentis [États-Unis] ; Maren Carbon [États-Unis] ; Rose-Marie Marié [France] | Executive processes in Parkinson's disease: FDG‐PET and network analysis |
001653 |
Mathias Pessiglione [France] ; Dominique Guehl [France] ; Caroline Jan [France] ; Chantal François [France] ; Etienne C. Hirsch [France] ; Jean Féger [France] ; Léon Tremblay [France] | Disruption of self‐organized actions in monkeys with progressive MPTP‐induced parkinsonism: II. Effects of reward preference |
001664 |
Pierre Pollak [France] ; F. Tison [France] ; Olivier Rascol [France] ; A. Destée [France] ; J J Péré [France] ; J M Senard [France] ; F. Durif [France] ; I. Bourdeix [France] | Clozapine in drug induced psychosis in Parkinson’s disease: a randomised, placebo controlled study with open follow up |
001670 |
Céline Roose-Amsaleg [France] ; Yves Brygoo [France] ; Myriam Harry [France] | Ascomycete diversity in soil‐feeding termite nests and soils from a tropical rainforest |
001686 |
Jan Herzog [Allemagne] ; Jens Volkmann [Allemagne] ; Paul Krack [Allemagne, France] ; Florian Kopper [Allemagne] ; Monika Pötter [Allemagne] ; Delia Lorenz [Allemagne] ; Meike Steinbach [Allemagne] ; Stefan Klebe [Allemagne] ; Wolfgang Hamel [Allemagne] ; Bettina Schrader [Allemagne] ; Dieter Weinert [Allemagne] ; Dieter Müller [Allemagne] ; Hubertus M. Mehdorn [Allemagne] ; Günther Deuschl [Allemagne] | Two‐year follow‐up of subthalamic deep brain stimulation in Parkinson's disease |
001693 |
Olga Corti ; Cornelia Hampe ; Hana Koutnikova ; Fre De Ric Darios ; Sandrine Jacquier ; Annick Prigent ; Jean-Charles Robinson ; Laurent Pradier [France] ; Merle Ruberg ; Marc Mirande ; Etienne Hirsch ; Thomas Rooney [France] ; Alain Fournier [France] ; Alexis Brice | The p38 subunit of the aminoacyl-tRNA synthetase complex is a Parkin substrate: linking protein biosynthesis and neurodegeneration |
001708 |
Alan L. Whone [Royaume-Uni] ; Ray L. Watts [États-Unis] ; A. Jon Stoessl [Canada] ; Margaret Davis [États-Unis] ; Sven Reske [Allemagne] ; Claude Nahmias ; Anthony E. Lang [Canada] ; Olivier Rascol [France] ; Maria J. Ribeiro [France] ; Philippe Remy [France] ; Werner Poewe [Autriche] ; Robert A. Hauser [États-Unis] ; David J. Brooks [Royaume-Uni] | Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL‐PET study |
001712 |
Alexis Elbaz [France] ; Clotilde Levecque [France] ; Jacqueline Clavel [France] ; Jean-Sébastien Vidal [France] ; Florence Richard [France] ; Jean-René Corrèze [France] ; Bernard Delemotte [France] ; Philippe Amouyel [France] ; Annick Alpérovitch [France] ; Marie-Christine Chartier-Harlin [France] ; Christophe Tzourio [France] | S18Y polymorphism in the UCH‐L1 gene and Parkinson's disease: Evidence for an age‐dependent relationship |
001729 |
Fre De Ric Darios ; Olga Corti ; Christoph B. Lu Cking ; Cornelia Hampe ; Marie-Paule Muriel ; Nacer Abbas ; Wen-Jie Gu ; Etienne C. Hirsch ; Thomas Rooney [France] ; Merle Ruberg ; Alexis Brice | Parkin prevents mitochondrial swelling and cytochrome c release in mitochondria-dependent cell death |
001730 |
Magali Periquet ; Morwena Latouche ; Ebba Lohmann ; Nina Rawal ; Giuseppe De Michele ; Sylvain Ricard ; He Lio Teive ; Vale Rie Fraix ; Marie Vidailhet ; David Nicholl ; Paolo Barone ; Nick W. Wood ; Salmo Raskin ; Jean-Franc Ois Deleuze ; Yves Agid [France] ; Alexandra Du Rr ; Alexis Brice | Parkin mutations are frequent in patients with isolated early‐onset parkinsonism |
001732 |
Jean-Michel Itier ; Pablo Iba N Ez ; Mari A Angeles Mena ; Nacer Abbas ; Charles Cohen-Salmon ; Georg Andrees Bohme ; Michel Laville ; Jeremy Pratt ; Olga Corti ; Laurent Pradier ; Gwe Na Elle Ret ; Chantal Joubert ; Magali Periquet ; Francisco Araujo ; Julia Negroni ; Mari A Jose Casarejos ; Santiago Canals ; Rosa Solano ; Alba Serrano ; Eva Gallego ; Marina Sa Nchez ; Patrice Dene Fle ; Jesu S Benavides ; Gu Nter Tremp ; Thomas A. Rooney ; Alexis Brice [France] ; Justo Garci A De Ye Benes | Parkin gene inactivation alters behaviour and dopamine neurotransmission in the mouse |
001739 |
Stephane Hunot [France] ; E. C. Hirsch [France] | Neuroinflammatory processes in Parkinson's disease |
001748 |
Olivier Rascol [France] ; Pierre Payoux ; Fabienne Ory ; Joaquim J. Ferreira [Portugal] ; Christine Brefel-Courbon ; Jean-Louis Montastruc | Limitations of current Parkinson's disease therapy |
001757 |
Ebba Lohmann [France] ; Magali Periquet [France] ; Vincenzo Bonifati [Italie] ; Nick W. Wood [Royaume-Uni] ; Giuseppe De Michele [Italie] ; Anne-Marie Bonnet [France] ; Valérie Fraix [France] ; Emmanuel Broussolle [France] ; Martin W. I. M. Horstink [Pays-Bas] ; Marie Vidailhet [France] ; Patrice Verpillat [France] ; Thomas Gasser [Allemagne] ; David Nicholl [Royaume-Uni] ; Hélio Teive [Brésil] ; Salmo Raskin [Brésil] ; Olivier Rascol [France] ; Alain Destée [France] ; Merle Ruberg [France] ; Francesca Gasparini [France] ; Giuseppe Meco [Italie] ; Yves Agid [France] ; Alexandra Durr [France] ; Alexis Brice [France] | How much phenotypic variation can be attributed to parkin genotype? |
001759 |
Yassine Darbaky [France] ; Claude Forni [France] ; Marianne Amalric [France] ; Christelle Baunez [France] | High frequency stimulation of the subthalamic nucleus has beneficial antiparkinsonian effects on motor functions in rats, but less efficiency in a choice reaction time task |
001766 |
Judit Várkonyi [Hongrie] ; Hanna Rosenbaum [Israël] ; Nicole Baumann [France] ; Jennifer J. Mackenzie [Canada] ; Zsuzsa Simon [Hongrie] ; Judith Aharon-Peretz [Israël] ; Jamie M. Walker [États-Unis] ; Nahid Tayebi [États-Unis] ; Ellen Sidransky [États-Unis] | Gaucher disease associated with parkinsonism: Four further case reports |
001771 |
Julie Hudry [France] ; Ste Phane Thobois ; Emmanuel Broussolle ; Patrice Adeleine ; Jean-Pierre Royet [France] | Evidence for Deficiencies in Perceptual and Semantic Olfactory Processesin Parkinson's Disease |
001776 |
Marc Ziegler ; Alexandre Castro-Caldas [Portugal] ; Susanna Del Signore [France] ; Olivier Rascol [France] | Efficacy of piribedil as early combination to levodopa in patients with stable Parkinson's disease: A 6‐month, randomized, placebo‐controlled study |
001779 |
C. Maurer ; T. Mergner ; J. Xie ; M. Faist ; Pierre Pollak [France] ; C. H. Lu Cking | Effect of chronic bilateral subthalamic nucleus (STN) stimulation on postural control in Parkinson’s disease |
001791 |
Patrice Péran [France] ; Olivier Rascol [France] ; Jean-François Démonet [France] ; Pierre Celsis [France] ; Jean-Luc Nespoulous [France] ; Bruno Dubois [France] ; Dominique Cardebat [France] | Deficit of verb generation in nondemented patients with Parkinson's disease |
001800 |
Frédéric Courbon [France] ; Christine Brefel-Courbon [France] ; Claire Thalamas [France] ; Marie Jeanne Alibelli [France] ; Isabelle Berry [France] ; Jean-Louis Montastruc [France] ; Olivier Rascol [France] ; Jean-Michel Senard [France] | Cardiac MIBG scintigraphy is a sensitive tool for detecting cardiac sympathetic denervation in Parkinson's disease |
001804 |
Clotilde Levecque ; Alexis Elbaz ; Jacqueline Clavel ; Florence Richard ; Jean-Se Bastien Vidal [France] ; Philippe Amouyel ; Christophe Tzourio ; Annick Alpe Rovitch ; Marie-Christine Chartier-Harlin | Association between Parkinson's disease and polymorphisms in the nNOS and iNOS genes in a community-based case–control study |
001817 |
Pierre Pollak [France] ; Valérie Fraix [France] ; Paul Krack [France] ; Elena Moro [France] ; Alexandre Mendes [France] ; Stephan Chabardes [France] ; Adnan Koudsie [France] ; Alim-Louis Benabid [France] | Treatment results: Parkinson's disease |
001828 |
P. H. Robert [France] ; S. Clairet [France] ; M. Benoit [France] ; J. Koutaich [France] ; C. Bertogliati [France] ; O. Tible [France] ; H. Caci [France] ; M. Borg [France] ; P. Brocker [France] ; P. Bedoucha [France] | The Apathy Inventory: assessment of apathy and awareness in Alzheimer's disease, Parkinson's disease and mild cognitive impairment |
001834 |
Paul Krack [France] ; Jonathan Dostrovsky [Canada] ; Igor Ilinsky [États-Unis] ; Kristy Kultas-Ilinsky [États-Unis] ; Fred Lenz [États-Unis] ; Andres Lozano [Canada] ; Jerry Vitek [États-Unis] | Surgery of the motor thalamus: Problems with the present nomenclatures |
001850 |
Marie Sarazin [France] ; Bernard Deweer [France] ; Angela Merkl [France] ; Natalia Von Poser [France] ; Bernard Pillon [France] ; Bruno Dubois [France] | Procedural learning and striatofrontal dysfunction in Parkinson's disease |
001855 |
Paul Krack [France] ; Valérie Fraix [France] ; Alexandre Mendes [France] ; Alim-Louis Benabid [France] ; Pierre Pollak [France] | Postoperative management of subthalamic nucleus stimulation for Parkinson's disease |
001869 |
P. Volders [Belgique] ; J. Van Hove [Belgique] ; R. J. U. Lories [Belgique] ; Ph. Vandekerckhove [Belgique] ; G. Matthijs [Belgique] ; R. De Vos [Belgique] ; M. T. Vanier [France] ; M. F. Vincent [Belgique] ; R. Westhovens [Belgique] ; F. P. Luyten [Belgique] | Niemann‐Pick disease type B: An unusual clinical presentation with multiple vertebral fractures |
001870 |
Bernard Pillon [France] | Neuropsychological assessment for management of patients with deep brain stimulation |
001871 |
Viel [France] ; Dominique Perennou [France] ; Jacques Ripari [France] ; Jacques Pélissier [France] ; Jean J. Eledjam [France] | Neurolytic blockade of the obturator nerve for intractable spasticity of adductor thigh muscles |
001921 |
Andrew West [États-Unis] ; Magali Periquet [France] ; Sarah Lincoln [États-Unis] ; Christoph B. Lücking [France, Allemagne] ; David Nicholl [Royaume-Uni] ; Vincenzo Bonifati ; Nina Rawal [France] ; Thomas Gasser [Allemagne] ; Ebba Lohmann [France] ; Jean-François Deleuze [France] ; Demetrius Maraganore [États-Unis] ; Allan Levey [Géorgie (pays)] ; Nick Wood [Royaume-Uni] ; Alexandra Dürr [France] ; John Hardy [États-Unis] ; Alexis Brice [France] ; Matt Farrer [États-Unis] | Complex relationship between Parkin mutations and Parkinson disease |
001979 |
A. Laumonnier ; J. P. Bleton [France] | Rehabilitacin en el tratamiento de la enfermedad de Parkinson |
001A04 |
Stéphane Hunot [France] ; Andreas Hartmann [France] ; Etienne C. Hirsch [France] | The inflammatory response in the Parkinson brain |
001A33 |
Marie-Paule Muriel [France] ; Yves Agid [France] ; Etienne Hirsch [France] | Plasticity of afferent fibers to striatal neurons bearing D1 dopamine receptors in Parkinson's disease |
001A39 |
Martin Zarate-Lagunes [France] ; Wen-Jie Gu [France] ; Véronique Blanchard [France] ; Chantal Francois [France] ; Marie-Paule Muriel [France] ; Annick Mouatt-Prigent [France] ; Bruno Bonici [France] ; André Parent [France] ; Andreas Hartmann [France] ; Jérôme Yelnik [France] ; Georg A. Boehme [France] ; Laurent Pradier [France] ; Saliha Moussaoui [France] ; Baptiste Faucheux [France] ; Rita Raisman-Vozari [France] ; Yves Agid [France] ; Alexis Brice [France] ; Etienne C. Hirsch [France] | Parkin immunoreactivity in the brain of human and non‐human primates: An immunohistochemical analysis in normal conditions and in Parkinsonian syndromes |
001A47 |
Kathy Dujardin ; Luc Defebvre [France] ; Christine Grunberg ; Estelle Becquet ; Alain Deste E | Memory and executive function in sporadic and familial Parkinson's disease |
001A77 |
M. Faist ; J. Xie [France] ; D. Kurz ; W. Berger ; C. Maurer ; Pierre Pollak [France] ; C. H. Lu Cking | Effect of bilateral subthalamic nucleus stimulation on gait in Parkinson's disease |
001A87 |
Patricia Dowsey-Limousin [Royaume-Uni] ; Pierre Pollak [France] | Deep brain stimulation in the treatment of Parkinson's disease: a review and update |
001A89 |
S. Thobois [France] ; S. Guillouet [France] ; E. Broussolle [France] | Contributions of PET and SPECT to the understanding of the pathophysiology of Parkinson’s disease |
001A90 |
Alberto Albanese [Italie] ; Ubaldo Bonuccelli [Italie] ; Christine Brefel [France] ; K. Ray Chaudhuri [Royaume-Uni] ; Carlo Colosimo [Italie] ; Tobias Eichhorn [Allemagne] ; Eldad Melamed [Israël] ; Pierre Pollak [France] ; Teus Van Laar [Pays-Bas] ; Mario Zappia [Italie] | Consensus statement on the role of acute dopaminergic challenge in Parkinson's disease |
001B04 |
Sylvain M. Chauvaud [France] ; Gianluca Brancaccio [France] ; Alain F. Carpentier [France] | Cardiac arrhythmia in patients undergoing surgical repair of Ebstein’s anomaly |
001B21 |
Alim-Louis Benabid [France] ; Adnan Koudsié [France] ; Abdelhamid Benazzouz [France] ; Valérie Fraix [France] ; Ahmed Ashraf [France] ; Jean François Le Bas [France] ; Stéphan Chabardes [France] ; Pierre Pollak [France] | Subthalamic Stimulation for Parkinson's Disease |
001B37 |
V. Ben [France] ; B. Bruguerolle [France] | Effects of bilateral striatal 6-OHDA lesions on circadian rhythms in the rat |
001B46 |
M. P. Le Bot-Lé Borgne [France] ; S. Robineau [France] ; M. Vérin [France] ; R. Brissot [France] ; P. Gallien [France] | Examen urodynamique et pathologies extrapyramidales. Étude à propos de 52 patients |
001B50 |
K. Ancolio [France] ; C. Alves Da Costa [France] ; K. Uéda [Japon] ; F. Checler [France] | α-Synuclein and the Parkinson's disease-related mutant Ala53Thr-α-synuclein do not undergo proteasomal degradation in HEK293 and neuronal cells |
001B69 |
Sophie Callier [Canada, France] ; Marc Morissette [Canada] ; Michelle Grbois [Canada] ; Thérèse Di Paolo [Canada] | Stereospecific prevention by 17β‐estradiol of MPTP‐induced dopamine depletion in mice |
001B71 |
A.-C. Bachoud-Lévi [France] ; C. Bourdet [France] ; P. Brugières [France] ; J.-P. Nguyen [France] ; T. Grandmougin [France] ; B. Haddad [France] ; R. Jény [France] ; P. Bartolomeo [France] ; M.-F. Boissé [France] ; G. Dalla Barba [France] ; J.-D. Degos [France] ; A.-M. Ergis [France] ; J.-P. Lefaucheur [France] ; F. Lisovoski [France] ; E. Pailhous [France] ; P. Rémy [France] ; S. Palfi [France] ; G. L. Defer [France] ; P. Cesaro [France] ; P. Hantraye [France] ; M. Peschanski [France] | Safety and Tolerability Assessment of Intrastriatal Neural Allografts in Five Patients with Huntington's Disease |
001C47 |
G. Münch [Allemagne] ; H. J. Lüth [Allemagne] ; A. Wong [Allemagne] ; Th. Arendt [Allemagne] ; E. Hirsch [France] ; R. Ravid [Pays-Bas] ; P. Riederer [Allemagne] | Crosslinking of α-synuclein by advanced glycation endproducts — an early pathophysiological step in Lewy body formation? |
001C49 |
C. Scherfler [Autriche] ; Z. Puschban [Autriche] ; I. Ghorayeb [France] ; G. P Goebel [Autriche] ; F. Tison [France] ; K. Jellinger [Autriche] ; Werner Poewe [Autriche] ; G. K Wenning [Autriche] | Complex motor disturbances in a sequential double lesion rat model of striatonigral degeneration (multiple system atrophy) |
001C50 |
S. Blanchet ; R. M. Marié [France] ; F. Dauvillier ; B. Landeau ; K. Benali ; F. Eustache [France] ; C. Chavoix | Cognitive processes involved in delayed non‐matching‐to‐sample performance in Parkinson's disease |
001C70 |
David S. Fedson [France] ; J. Anthony [Royaume-Uni] ; G. Scott [États-Unis] | The burden of pneumococcal disease among adults in developed and developing countries: what is and is not known |
001C98 |
Federico A. Dajas-Bailador [Uruguay, Royaume-Uni] ; Marcelo Asencio [Chili] ; Carolina Bonilla [Uruguay] ; Ma. Cecilia Scorza [Uruguay] ; Carolina Echeverry [Uruguay] ; Miguel Reyes-Parada [Uruguay] ; Rodolfo Silveira [Uruguay] ; Philippe Protais [France] ; Graeme Russell [Nouvelle-Zélande] ; Bruce K. Cassels [Chili] ; Federico Dajas [Uruguay] | Dopaminergic pharmacology and antioxidant properties of pukateine, a natural product lead for the design of agents increasing dopamine neurotransmission |
001D09 |
D. Brassat [France] ; A. Durr [France] ; Yves Agid [France] ; A. Brice [France] | Génétique de la maladie de Parkinson |
001D10 |
L. Defebvre [France] ; P. Derambure [France] ; J. L. Bourriez [France] ; A. Destée [France] ; J. D. Guieu [France] | Désynchronisation liée à l'événement et maladie de Parkinson. Intérêt dans l'analyse de la phase de préparation au mouvement |
001D20 |
Jean Louis Montastruc [France] ; Olivier Rascol [France] ; Jean-Michel Senard [France] | Treatment of Parkinson's disease should begin with a dopamine agonist |
001D25 |
P. Damier ; E. C. Hirsch ; Yves Agid [France] ; A. M. Graybiel | The substantia nigra of the human brain |
001D55 |
A. M. Bonnet [France] ; J. L. Houeto [France] | Pathophysiology of Parkinson's disease |
001D61 |
Martin Goulet ; Marc Morissette ; Richard Grondin ; Pierre Falardeau ; Paul J. Bédard ; William Rostène [France] ; Thérèse Di Paolo | Neurotensin receptors and dopamine transporters: Effects of MPTP lesioning and chronic dopaminergic treatments in monkeys |
001D71 |
Marie-Paule Muriel [France] ; Véronique Bernard [France] ; Allan I. Levey [États-Unis] ; Ouahiba Laribi [France] ; D. Nora Abrous [France] ; Yves Agid [France] ; Bertrand Bloch [France] ; Etienne C. Hirsch [France] | Levodopa induces a cytoplasmic localization of D1 dopamine receptors in striatal neurons in Parkinson's disease |
001D80 |
R. G. Brown [Royaume-Uni] ; P. Limousin Dowsey [Royaume-Uni, France] ; P. Brown [Royaume-Uni] ; M. Jahanshahi [Royaume-Uni] ; Pierre Pollak [France] ; Alim-Louis Benabid [France] ; M. C. Rodriguez-Oroz [Espagne] ; J. Obeso [Espagne] ; J. C. Rothwell [Royaume-Uni] | Impact of deep brain stimulation on upper limb akinesia in Parkinson's disease |
001D87 |
Paul Krack ; Pierre Pollak [France] ; Patricia Limousin ; Abdelhamid Benazzouz ; Gu Nther Deuschl ; Alim-Louis Benabid [France] | From off-period dystonia to peak-dose chorea |
001D98 |
Fred Brown [États-Unis] ; Nadia Benkirane [France] ; David Limal [France] ; Hubert Halimi [France] ; John F. E Newman [États-Unis] ; Marc H. V Van Regenmortel [France] ; Jean-Paul Briand [France] ; Sylviane Muller [France] | Delineation of a neutralizing subregion within the immunodominant epitope (GH loop) of foot-and-mouth disease virus VP1 which does not contain the RGD motif |
001E06 |
Laurent Vercueil [France] ; Jean Pierre Linard [France] ; Bernard Wuyam [France] ; Pierre Pollak [France] ; Gila Benchetrit [France] | Breathing pattern in patients with Parkinson’s disease |
001E17 |
Jean-Louis Montastruc [France] ; Marc Ziegler [France] ; Olivier Rascol [France] ; Muriel Malbezin [France] | A randomized, double‐blind study of a skin patch of a dopaminergic agonist, piribedil, in Parkinson's disease |
001E43 |
E. Villain [France] ; D. Bonnet [France] ; P. Acar [France] ; Y. Aggoun [France] ; D. Sidi [France] ; J. Kachaner [France] | Recommandations pour le traitement des tachycardies supraventriculaires réciproques du nourrisson |
001E44 |
Jp Azulay [France] | Manipulation visuelle sensorielle et contrôle postural chez le parkinsonien |
001E63 |
Rascol [France] ; David J. Brooks [Royaume-Uni] ; Ehrout R. Brunt [Pays-Bas] ; Amos D. Korczyn [Israël] ; Warner H. Poewe [Autriche] ; Fabrizzio Stocchi [Italie] | Ropinirole in the treatment of early Parkinson's disease: A 6‐month interim report of a 5‐year levodopa‐controlled study |
001E81 |
S. Palfi [France] ; J. P. Nguyen [France] ; P. Brugieres [France] ; C. Le Guerinel [France] ; P. Hantraye [France] ; P. Remy [France] ; S. Rostaing [France] ; G. L. Defer [France] ; P. Cesaro [France] ; Y. Keravel [France] ; M. Peschanski [France] | MRI-Stereotactical Approach for Neural Grafting in Basal Ganglia Disorders |
001E90 |
Hirsch [France] ; S. Hunot [France] ; P. Damier [France] ; B. Faucheux [France] | Glial cells and inflammation in parkinson's disease: A role in neurodegeneration? |
001F06 |
A. Nicole [France] ; D. Santiard-Baron [France] ; I. Ceballos-Picot [France] | Direct evidence for glutathione as mediator of apoptosis in neuronal cells |
001F18 |
Murer [France] ; Gustavo Dziewczapolski [Argentine] ; Liliana B. Menalled [Argentine] ; M. Carmen García [Argentine] ; Yves Agid [France] ; Oscar Gershanik [Argentine] ; Rita Raisman-Vozari [France] | Chronic levodopa is not toxic for remaining dopamine neurons, but instead promotes their recovery, in rats with moderate nigrostriatal lesions |
001F21 |
Johann Tassin ; Alexandra Dürr ; Thomas De Broucker [France] ; Nacer Abbas ; Vincenzo Bonifati ; Giuseppe De Michele ; Anne-Marie Bonnet ; Emmanuel Broussolle ; Pierre Pollak [France] ; Marie Vidailhet ; Michele De Mari ; Roberto Marconi [Italie] ; Soraya Medjbeur ; Allessandro Filla ; Giuseppe Meco ; Yves Agid [France] ; Alexis Brice [France] | Chromosome 6–Linked Autosomal Recessive Early-Onset Parkinsonism: Linkage in European and Algerian Families, Extension of the Clinical Spectrum, and Evidence of a Small Homozygous Deletion in One Family |
001F31 |
S. Lévy [France] ; P. Ricard [France] | Using the right drug: A treatment algorithm for regular supraventricular tachycardias |
001F34 |
John Parkinson [Royaume-Uni] ; Andy Brass [Royaume-Uni] ; Giles Canova [France] ; Yves Brechet [France] | The mechanical properties of simulated collagen fibrils |
001F72 |
F. Sellai [France] | Les démences sous-corticales |
001F76 |
Bonnet [France] ; J. Pichon [France] ; M. Vidailhet [France] ; N. Gouider-Khouja [France] ; G. Robain [France] ; M. Perrigot [France] ; Yves Agid [France] | Urinary disturbances in striatonigral degeneration and parkinson's disease: Clinical and urodynamic aspects |
002077 |
Béatrice Brembilla-Perrot [France] ; Daniel Beurrier [France] ; Arnaud Terrier De La Chaise [France] ; Christine Suty-Selton [France] ; Laurent Jacquemin [France] ; Bernard Thiel [France] ; Pierre Louis [France] | Significance and prevalence of inducible atrial tachyarrhythmias in patients undergoing electrophysiologic study for presyncope or syncope |
002108 |
Peter F. Dominey [France] ; Jocelyne Ventre-Dominey [France] ; Emannuel Broussolle [France] ; Marc Jeannerod [France] | Analogical transfer is effective in a serial reaction time task in Parkinson's disease: Evidence for a dissociable form of sequence learning |
002123 |
Hugues Duffau [France] ; Nathalie Tzourio [France] ; Dominique Caparros-Lefebvre [France] ; Fabrice Parker [France] ; Bernard Mazoyer [France] | Tremor and voluntary repetitive movement in Parkinson's disease: comparison before and after l -dopa with positron emission tomography |
002133 |
Philippe Anglade [France] ; Annick Mouatt-Prigent [France] ; Yves Agid [France] ; Etienne C. Hirsch [France] | Synaptic Plasticity in the Caudate Nucleus of Patients with Parkinson's Disease |
002136 |
Brigitte Piallat [France] ; Abdelhamid Benazzouz [France] ; Alim-Louis Benabid [France] | Subthalamic Nucleus Lesion in Rats Prevents Dopaminergic Nigral Neuron Degeneration After Striatal 6‐OHDA Injection: Behavioural and Immunohistochemical Studies |
002151 |
F. Tison [France] ; K. Wenning [Autriche] ; A. Volonte [Italie] ; R. Poewe [Autriche] ; P. Henry [France] ; P. Quinn [Royaume-Uni] | Pain in multiple system atrophy |
002155 |
S. Hunot [France] ; F. Boissière [France] ; B. Faucheux [France] ; B. Brugg [France] ; A. Mouatt-Prigent [France] ; Yves Agid [France] ; E. C. Hirsch [France] | Nitric oxide synthase and neuronal vulnerability in parkinson's disease |
002158 |
G. Lucotte [France] ; J. Turpin [France] ; N. Gérard [France] ; S. Panserat [France] ; R. Krishnamoorthy [France] | Mutation frequencies of the cytochrome CYP2D6 gene in Parkinson disease patients and in families |
002167 |
A. Mouatt-Prigent [France] ; J. O. Karlsson [Suède] ; Yves Agid [France] ; E. C. Hirsch [France] | Increased m-calpain expression in the mesencephalon of patients with parkinson's disease but not in other neurodegenerative disorders involving the mesencephalon: a role in nerve cell death? |
002175 |
S. Hunot [France] ; V. Bernard [France] ; B. Faucheux [France] ; F. Boissière [France] ; E. Leguern [France] ; C. Brana [France] ; P. Gautris [France] ; J. Guérin [France] ; B. Bloch [France] ; Yves Agid [France] ; C. Hirsch [France] | Glial cell line-derived neurotrophic factor (GDNF) gene expression in the human brain: A post mortem in situ hybridization study with special reference to Parkinson's disease |
002194 |
F. Durif [France] ; E. Albuisson [France] ; B. Debilly [France] ; J. F. Le Bas [France] ; Pierre Pollak [France] | Comparison of cerebral atrophy evaluated by MRI in Parkinson's disease and multiple system atrophy |
002200 |
B. Leveugle [États-Unis] ; B. A. Faucheux ; C. Bouras [États-Unis] ; N. Nillesse ; G. Spik ; E. C. Hirsch ; Yves Agid [France] ; P. R. Hof [États-Unis] | Cellular distribution of the iron-binding protein lactotransferrin in the mesencephalon of Parkinson’s disease cases |
002203 |
L. García-Larrea [France] ; E. Brousolle [France] ; M. F. Gravejat [France] ; G. Chazot [France] ; F. Mauguière [France] | Brain Responses to Detection of Right or Left Somatic Targets are Symmetrical in Unilateral Parkinson's Disease: A Case Against the Concept of ‘Parkinsonian Neglect’ |
002238 |
Christian Geny [France] ; Souad Naimi-Sadaoui [France, Maroc] ; Abd El Madjid Belkadi [France] ; Roland Jeny [France] ; Mourad Kammoun [France] ; Marc Peschanski [France] | Microglial chimaerism in human xenografts to the rat brain |
002264 |
V. Planté-Bordeneuve [France] ; D. Taussig [France] ; F. Thomas [France] ; M. Ziégler [France] ; G. Said [France] | A clinical and genetic study of familial cases of Parkinson's disease |
002283 |
F. Thibaut [France] ; B. A. Faucheux [France] ; J. Marquez [France] ; J. Villares [France] ; J. F. Menard [France] ; Yves Agid [France] ; E. C. Hirsch [France] | Regional distribution of monoamine vesicular uptake sites in the mesencephalon of control subjects and patients with Parkinson's disease: a postmortem study using tritiated tetrabenazine |
002295 |
Philippe Anglade [France] ; France Javoy-Agid [France] ; Yves Agidm [France] ; Etienne C. Hirsch [France] ; Shigeru Tsuji [France] | Plasticity of nerve afferents to nigrostriatal neurons in parkinson's disease |
002299 |
-M. Marié [France] ; L. Barré [France] ; P. Rioux [France] ; P. Allain [France] ; B. Lechevalier [France] ; -C. Baron [France] | PET imaging of neocortical monoaminergic terminals in Parkinson's disease |
002307 |
John Maurice [France] | Nerve growth factor: A plethora of possibilities |
002331 |
H. Allain [France] ; A. Lieury [France] ; V. Thomas [France] ; J. M. Reymann [France] ; J. M. Gandon [France] ; S. Belliard [France] | Explicit and procedural memory in Parkinson's disease |
002344 |
Campion [France] ; M. Martinez [France] ; D. Hannequin ; A. Brice [France] ; C. Thomas-Anterion [France] ; A. Michon [France] ; M. C. Babron [France] ; B. Dubois [France] ; Y. Goas [France] ; A. Jaillard-Serradt [France] ; F. Ledoze [France] ; F. Pasquier [France] ; M. Puel [France] ; M. A. Zimmerman [France] ; M. Bellis [France] ; J. Mallet [France] ; Yves Agid [France] ; F. Clerget-Darpoux [France] | Characteristics of familial aggregation in early‐onset Alzheimer's disease: Evidence of subgroups |
002352 |
G. Mathé [France] | Can an adjuvant treatment or a pharmacologic prevention be common to several diseases? The case of those associated to neuromediator defects |
002357 |
D. Muguet [France] ; E. Broussolle [France] ; G. Chazot [France] | Apomorphine in patients with Parkinson's disease |
002365 |
P. Davous [France] ; P. Auquier [France] ; S. Grignon [France] ; H. C. Neukirch [France] | A prospective study of depression in French patients with Parkinson's disease. The Depar study |
002379 |
A. Delacourte [France] | Pathological Tau proteins of Alzheimer's disease as a biochemical marker of neurofibrillary degeneration |
002383 |
O. Blin [France] ; C. Desnuelle [France] ; Olivier Rascol [France] ; M. Borg [France] ; H. Peyro Saint Paul [France] ; J. P. Azulay [France] ; F. Billé [France] ; D. Figarella [France] ; F. Coulom [France] ; J. F. Pellissier [France] ; J. L. Montastruc [France] ; M. Chatel [France] ; G. Serratrice [France] | Mitochondrial respiratory failure in skeletal muscle from patients with Parkinson's disease and multiple system atrophy |
002391 |
V. Jorgetti [France] ; N. M. Ricco Soeiro [France] ; V. Mendes [France] ; R. C. Pereira [France] ; M. E. Crivellari [France] ; G. Coutris [France] ; A. Borelli [France] ; M. O. Ribeiro Leite [France] ; I. Nussenzweig [France] ; M. Marcondes [France] ; T. Drüeke [France] ; G. Cournot [France] | Aluminium-related osteodystrophy and desferrioxamine treatment: role of phosphorus |
002393 |
A. Autret [France] ; B. Lucas [France] ; F. Henry [France] ; D. Saudeau [France] ; B. De Toffol [France] | Influence du sommeil sur les mouvements anormaux de la veille |
002410 |
Josiane Holstein [France] ; Gilles Chatellier [France] ; François Piette [France] ; Robert Moulias [France] | Prevalence of Associated Diseases in Different Types of Dementia Among Elderly Institutionalized Patients: Analysis of 3447 Records |
002424 |
Stéphane Lehéricy [France] ; Jean-Philippe Brandel [France] ; Etienne C. Hirsch [France] ; Philippe Anglade [France] ; Joao Villares [France] ; Daniel Scherman [France] ; Charles Duyckaerts [France] ; France Javoy-Agid [France] ; Yves Agid [France] | Monoamine vesicular uptake sites in patients with Parkinson's disease and Alzheimer's disease, as measured by tritiated dihydrotetrabenazine autoradiography |
002428 |
Roberto Marconi [France, Italie] ; Dominique Lefebvre-Caparros [France] ; Anne-Marie Bonnet [France] ; Marie Vidailhet [France] ; Bruno Dubois [France] ; Agid [France] | Levodopa‐induced dyskinesias in Parkinson's disease phenomenology and pathophysiology |
002429 |
Michel Haïssaguerre [France] ; Julio Campos [Portugal] ; Frank I. Marcus [États-Unis] ; Gérard Papouin [France] ; Jacques Clémenty [France] | Involvement of a Nodofascicular Connection in Supraventricular Tachycardia with VA Dissociation |
002445 |
Annick Mouatt-Prigent [France] ; Yves Agid [France] ; Etienne C. Hirsch [France] | Does the calcium binding protein calretinin protect dopaminergic neurons against degeneration in Parkinson's disease? |
002457 |
Jeswinder Sian ; David T. Dexter ; Andrew Lees (neurologue) [Royaume-Uni] ; Susan Daniel [Royaume-Uni] ; Yves Agid [France] ; France Javoy-Agid [France] ; Peter Jenner ; C. David Marsden [Royaume-Uni] | Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia |
002483 |
R. Gil [France] ; L. Zai [France] ; J. P. Neau [France] ; T. Jonveaux [France] ; C. Agbo [France] ; T. Rosolacci [France] ; P. Burbaud [France] ; P. Ingrand [France] | Event-related auditory evoked potentials and multiple sclerosis |
002496 |
C. Corbe [France] ; F. Arnaud [France] ; Y. Brault [France] ; C. Janiak-Bolzinger [France] | Effet d'un agoniste dopaminergique, le piribédil (Trivastal 50 mg LP) sur l'intégration visuelle spatiale du sujet âgé |
002497 |
B. Dubois [France] ; B. Pillon [France] ; Yves Agid [France] | Détérioration des voies dopaminergiques et altérations des fonctions cognitives et motrices |
002498 |
P. Rondot [France] ; M. Ziegler [France] | Activité et acceptabilité du piribédil dans la maladie de Parkinson: étude multicentrique |
002523 |
E. Nicolle [France] ; Pierre Pollak [France] ; F. Serre-Debeauvais [France] ; P. Richard [France] ; Cl Gervason [France] ; E. Broussolle [France] ; M. Gavend [France] | Pharmacokinetics of apomorphine in parkinsonian patients |
002536 |
Gai [Australie] ; Geffen [Australie] ; L. Denoroy [France] ; W. W. Blessing [Australie] | Loss of C1 and C3 epinephrine‐synthesizing neurons in the medulla oblongata in parkinson's disease |
002551 |
G. Masson [France] ; D. Mestre [France] ; O. Blin [France] | Dopaminergic modulation of visual sensitivity in man |
002554 |
M. T. Herrero [France] ; E. C. Hirsch [France] ; A. Kastner [France] ; M. Ruberg [France] ; M. R. Luquin [Espagne] ; J. Laguna [Espagne] ; F. Javoy-Agid [France] ; J. A. Obeso [Espagne] ; Yves Agid [Espagne] | Does neuromelanin contribute to the vulnerability of catecholaminergic neurons in monkeys intoxicated with MPTP? |
002558 |
Patrick Vermersch ; Delacourte ; France Javoy-Agid [France] ; Jean-Jacques Hauw [France] ; Yves Agid [France] | Dementia in Parkinson's disease: Biochemical evidence for cortical involvement using the immunodetection of abnormal tau proteins |
002603 |
J. C. Pin [France] ; J. P. Neau [France] ; J. Paquereau [France] ; C. Rostykus [France] ; D. Guehl [France] ; I. Aubert [France] ; A. Marillaud [France] ; R. Gil [France] | Étude comparative de la démence de type Alzheimer et de celle de la maladie de Parkinson en EEG quantifiée |
002623 |
Geneviève Durrieu [France] ; Marie-Elise Llau [France] ; Olivier Rascol [France] ; Jean-Michel Senard [France] ; André Rascol [France] ; Jean-Louis Montastruc [France] | Parkinson's disease and weight loss: A study with anthropometric and nutritional assessment |
002636 |
C. Corbe [France] ; F. Arnaud [France] ; Y. Brault [France] ; C. Janiak-Bolzinger [France] | Effect of a dopaminergic agonist, piribedil (Trivastal 50 mg LP), on visual and spatial integration in elderly subjects |
002648 |
Jean-Michel Senard [France] ; Bernard Chamontin [France] ; André Rascol [France] ; Jean-Louis Montastruc [France] | Ambulatory blood pressure in patients with Parkinson's disease without and with orthostatic hypotension |
002650 |
P. Rondot [France] ; M. Ziegler [France] | Activity and acceptability of piribedil in Parkinson's disease: a multicentre study |
002654 |
G. Vallet [Suisse] ; R. Guntern [Suisse] ; R. Hof [États-Unis] ; J. Golaz [Suisse] ; A. Delacourte [France] ; K. Robakis [États-Unis] ; C. Bouras | A comparative study of histological and immunohistochemical methods for neurofibrillary tangles and senile plaques in Alzheimer's disease |
002655 |
P. Torner ; P. Brugada ; J. Smeets ; M. Talajic ; P. Della Bella ; R. Lezaun ; A. V. D. Dool ; H. J. J. Wellens ; A. Bayés De Luna [Espagne] ; R. Oter [Espagne] ; G. Breithardt ; M. Borggrefe ; H. Klein ; K. H. Kuck [Allemagne] ; K. Kunze [Allemagne] ; P. Coumel ; J. F. Leclercq ; F. Chouty ; R. Frank [France] ; G. Fontanine [France] | Ventricular fibrillation in the Wolff-Parkinson-White syndrome |
002667 |
G. Kenneth Lloyd [France] ; Armand Lowenthal [Belgique] ; France Javoy-Agid [France] ; Jean Constantidinis [Suisse] | GAEAA receptor complex function in frontal cortex membranes from control and neurological patients |
002671 |
M. Haissaguerre [France] ; P. Montserrat [France] ; J. F. Warin [France] ; J. P. Donzeau [France] ; P. Le Metayer [France] ; J. P. Massiere [France] | Catheter ablation of left posteroseptal accessory pathways and of long RP′ tachycardias with a right endocardial approach |
002675 |
Ap Feve [France] ; N. Bathien [France] ; P. Rondot [France] | Évolution des potentiels corticaux liés au mouvement chez les patients parkinsoniens, avant et après traitement par la lévodopa |
002682 |
H. Allain [France] ; J. Cougnard [France] ; H-C. Neukirch [France] | Selegiline in de novo parkinsonian patients: The French selegiline multicenter trial (FSMT) |
002724 |
Gaspar [France] ; Charles Duyckaerts [France] ; Chantal Alvarez [France] ; France Javoy-Agid [France] ; Brigitte Berger [France] | Alterations of dopaminergic and noradrenergic innervations in motor cortex in parkinson's disease |
002726 |
Anne-Marie Ferrandez [France] ; Olivier Blin | A comparison between the effect of intentional modulations and the action of l-Dopa on gait in Parkinson's disease |
002768 |
Roger Deloncle [France] ; Olivier Guillard [France] | Mechanism of Alzheimer's disease: Arguments for a neurotransmitter-aluminium complex implication |
002771 |
R. Raisman-Vozari ; J.-A. Girault [États-Unis] ; S. Moussaoui ; C. Feuerstein ; P. Jenner ; C. D. Marsden ; Yves Agid [France] | Lack of change in striatal DARPP-32 levels following nigrostriatal dopaminergic lesions in animals and in parkinsonian syndromes in man |
002793 |
B. Brembilla-Perrot [France] ; A. Terrier De La Chaise [France] ; M. Pichené [France] ; E. Aliot [France] ; F. Cherrier [France] ; C. Pernot [France] | Isoprenaline as an aid to the induction of catecholamine dependent supraventricular tachycardias during programmed stimulation. |
002810 |
M. Haissaguerre [France] ; J. F. Warin [France] | Closed-chest ablation of left lateral atrioventricular accessory pathways |
002812 |
Olivier Rascol [France] ; M. Clanet [France] ; J. L. Montastruc [France] ; M. Simonetta [France] ; M. J. Soulier-Esteve [France] ; B. Doyon [France] ; A. Rascol [France] | ABNORMAL OCULAR MOVEMENTS IN PARKINSON'S DISEASE |
002820 |
Scherman [France] ; Claire Desnos [France] ; François Darchen [France] ; Pierre Pollak [France] ; France Javoy-Agid [France] ; Yves Agid [France] | Striatal dopamine deficiency in parkinson's disease: Role of aging |
002843 |
Agid [France] ; Pascale Cervera [France] ; Etienne Hirsch [France] ; France Javoy-Agid [France] ; Stéphane Lehericy [France] ; Rita Raisman [France] ; Merle Ruberg [France] | Biochemistry of Parkinson's disease 28 years later: A critical review |
002849 |
O. Isacson [Royaume-Uni] ; D. Riche [France] ; P. Hantraye [France] ; V. Sofroniew [Royaume-Uni] ; M. Maziere [France] | A primate model of Huntington's disease: cross-species implantation of striatal precursor cells to the excitotoxically lesioned baboon caudate-putamen |
002864 |
Laurent Pierot [France] ; Claire Desnos [France] ; Jerome Blin [France] ; Rita Raisman [France] ; Daniel Scherman [France] ; France Javoy-Agid [France] ; Merle Ruberg [France] ; Yves Agid [France] | D1 and D2-type dopamine receptors in patients with Parkinson's disease and progressive supranuclear palsy |
002875 |
Viallet [France] ; D. Gambarelli [France] ; B. Alonzo [France] ; R. Sedan [France] ; R. Khalil [France] | Long‐term follow‐up after stereotaxic basal ganglia surgery in Parkinsonism. A neuroanatomical study of a case showing unusual postural disorders |
002880 |
J. Nguyen-Legros [France] | Functional neuroarchitecture of the retina: hypothesis on the dysfunction of retinal dopaminergic circuitry in Parkinson's disease |
002887 |
Maloteaux [Belgique] ; E. C. Laterre [Belgique] ; P. M. Laduron [France] ; F. Javoy-Agid [France] ; Yves Agid [France] | Decrease of serotonin‐S2 receptors in temporal cortex of patients with Parkinson's disease and progressive supranuclear palsy |
002892 |
F. Viallet [France] ; J. Massion [France] ; R. Massarino [France] ; R. Khalil [France] | Performance of a bimanual load-lifting task by parkinsonian patients. |
002921 |
D. Le Guludec ; M. Bourguignon [France] ; C. Sebag ; H. Valette [France] ; A. Sirinelli ; M. Davy ; A. Syrota [France] ; G. Motte | Phase mapping of radionuclide gated biventriculograms in patients with sustained ventricular tachycardia or Wolff-Parkinson-White syndrome |
002931 |
Dubois [France] ; François Danzé [France] ; Bernard Pillon [France] ; Guliana Cusimano [France] ; François Lhermitte [France] ; Yves Agid [France] | Cholinergic‐dependent cognitive deficits in Parkinson's disease |
002974 |
Paul Worms [France] ; Jean-Paul Kan [France] ; C. Wermuth [France] ; Kathleen Biziere [France] | Dopamine-like activities of an aminopyridazine derivative, CM 30366: A behavioural study |
002981 |
Merle Ruberg [France] ; François Rieger [France] ; Albert Villageois [France] ; Anne Marie Bonnet ; Yves Agid [France] | Acetylcholinesterase and butyrylcholinesterase in frontal cortex and cerebrospinal fluid of demented and non-demented patients with Parkinson's disease |
002994 |
Roland Cash [France] ; Rita Raisman [France] ; Alain Ploska [France] ; Yves Agid [France] | High and low affinity [3H]imipramine binding sites in control and Parkinsonian brains |
002999 |
Etienne Hirsch [France] ; Merle Ruberg [France] ; Mireille Dardenne [France] ; Marie-Madeleine Portier ; France Javoy-Agid [France] ; Jean-Francois Bach [France] ; Yves Agid [France] | monoclonal antibodies raised against Lewy bodies in brains from subjects with Parkinson's disease |
002A08 |
L. Pique [France] ; S. Jegou ; X. Bertagna [France] ; F. Javoy-Agid ; D. Seurin [France] ; M. F. Proeschel [France] ; F. Girard [France] ; Yves Agid [France] ; H. Vaudry ; J. P. Luton [France] | Pro-opiomelanocortin peptides in the human hypothalamus: Comparative study between normal subjects and parkinson patients |
002A16 |
Merle Ruberg [France] ; France Javoy-Agid [France] ; Etienne Hirsch [France] ; Bernard Scatton [France] ; Rémy Lheureux [France] ; Jean-Jacques Hauw [France] ; Charles Duyckaerts [France] ; Françloise Gray [France] ; Ariel Morel-Maroger [France] ; André Rascol [France] ; Michel Serdaru [France] ; Agid [France] | Dopaminergic and cholinergic lesions in progressive supranuclear palsy |
002A25 |
D. Rougemont ; J C Baron ; P. Collard ; P. Bustany ; D. Comar ; Yves Agid [France] | Local cerebral glucose utilisation in treated and untreated patients with Parkinson's disease. |
002A52 |
M. Van Den Brand [Pays-Bas] ; P. Serruys [Pays-Bas] ; Y. De Roon [Pays-Bas] ; F. Aymard [France, Pays-Bas] ; A. Dufour [France, Pays-Bas] | Haemodynamic effects of intravenous cibenzoline in patients with coronary heart disease |
002A57 |
P. Gaspar [France] ; F. Gray [France] | Dementia in idiopathic Parkinson's disease |
002A78 |
Bernard Scatton ; France Javoy-Agid [France] ; Liliane Rouquier ; Bruno Dubois [France] ; Yves Agid [France] | Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease |
002A98 |
Bruno Dunois ; Merle Ruberg ; France Javoy-Agid ; Alain Ploska ; Yves Agid [France] | A subcortico-cortical cholinergic system is affected in Parkinson's disease |
002B90 |
Brown [France] ; Françoise Cathala [France] ; Doris Sadowsky [France] ; D. C. Gajdusek [France] | Creutzfeldt‐Jakob disease in France: II. Clinical characteristics of 124 consecutive verified cases during the decade 1968–1977 |
002C19 |
Duckett [États-Unis, France] ; Pierre Galle [États-Unis, France] ; Richard Kradin [États-Unis, France] | The relationship between parkinson syndrome and vascular siderosis: An electron microprobe study |